data_2e6z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e6z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.427 HG12 ' ND2' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 434' ' ' ILE . 67.8 m-80 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.438 ' CD ' HD11 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.438 HD11 ' CD ' ' A' ' 452' ' ' PRO . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.493 ' CE1' HD12 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.446 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.408 ' ND2' HG12 ' A' ' 434' ' ' ILE . 6.8 m120 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.43 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.43 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.417 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.45 ' CG2' HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.467 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.426 ' CG ' HD12 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.45 HD22 ' CG2' ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.403 HG12 ' N ' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' HG12 ' A' ' 434' ' ' ILE . 22.1 p30 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.478 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.468 ' N ' HG23 ' A' ' 440' ' ' ILE . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 429' ' ' CYS . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . 0.445 ' N ' HG11 ' A' ' 428' ' ' VAL . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.462 HG12 ' N ' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.462 ' N ' HG12 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 440' ' ' ILE . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.477 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.459 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.421 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.527 HD12 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.459 HG22 ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 434' ' ' ILE . 19.2 p30 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.449 ' CD1' HG11 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' MET . . . . . 0.419 ' C ' HD13 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.45 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.527 ' CE1' HD12 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' MET . . . . . 0.486 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.41 ' HG3' ' C ' ' A' ' 436' ' ' LEU . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 429' ' ' CYS . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . 0.41 ' N ' HG11 ' A' ' 428' ' ' VAL . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.519 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.4 ' O ' ' CG ' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.41 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.469 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.417 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 431' ' ' GLY . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 19.2 p30 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 422' ' ' PRO . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.423 HG11 ' CD1' ' A' ' 448' ' ' ILE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.421 ' CD ' HD12 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.421 HD12 ' CD ' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.424 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . 0.409 ' N ' HG13 ' A' ' 428' ' ' VAL . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.458 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 461' ' ' LEU . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 469' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.4 ' CD1' HG12 ' A' ' 443' ' ' VAL . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.554 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 446' ' ' ASN . 0.0 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.542 ' CB ' ' CZ ' ' A' ' 463' ' ' PHE . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.452 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.461 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.47 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.416 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.454 ' CG1' HD13 ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.454 HD13 ' CG1' ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.475 ' CG2' ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.475 ' OD1' ' CG2' ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.479 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.446 ' N ' HG23 ' A' ' 440' ' ' ILE . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.479 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.468 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.468 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.469 ' N ' HG23 ' A' ' 440' ' ' ILE . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.45 ' CG ' HD12 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.45 HD12 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.41 ' C ' HG13 ' A' ' 426' ' ' VAL . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 425' ' ' ASN . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.503 HD11 ' CZ ' ' A' ' 463' ' ' PHE . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.468 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.445 ' CD1' HG11 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.461 HD23 ' CZ ' ' A' ' 463' ' ' PHE . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.461 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.411 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 440' ' ' ILE . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 446' ' ' ASN . 0.1 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . 0.462 ' CD1' HG11 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 456' ' ' ASP . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' MET . . . . . 0.436 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.512 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.466 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 440' ' ' ILE . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' CYS . . . . . 0.403 ' N ' HG11 ' A' ' 428' ' ' VAL . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 422' ' ' PRO . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.453 ' N ' HG22 ' A' ' 440' ' ' ILE . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 65.8 m -135.68 170.11 16.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.5 t -112.47 -63.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 161.95 119.49 0.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 50.5 m -54.9 162.05 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 3.2 t -72.92 122.88 22.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 148.38 -155.76 26.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -80.21 153.7 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.409 ' CG1' ' HA ' ' A' ' 470' ' ' LYS . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.427 HG12 ' ND2' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 434' ' ' ILE . 67.8 m-80 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.438 ' CD ' HD11 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.438 HD11 ' CD ' ' A' ' 452' ' ' PRO . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.493 ' CE1' HD12 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -142.12 139.01 32.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.409 ' HA ' ' CG1' ' A' ' 426' ' ' VAL . 16.1 pttp -79.96 124.95 29.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.1 t -110.59 144.95 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.6 m -56.23 168.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.52 -166.41 16.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 75.7 m -83.45 92.7 7.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 50.7 m -88.73 116.27 26.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.24 -139.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.71 149.22 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.446 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.408 ' ND2' HG12 ' A' ' 434' ' ' ILE . 6.8 m120 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.43 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.43 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.417 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -148.13 155.78 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -86.82 125.69 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 18.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 5.8 t -70.64 98.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.3 t -41.3 107.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 146.45 -70.75 0.35 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 11.0 m -43.95 126.84 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 42.4 p -109.08 131.59 54.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 135.65 -170.92 22.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -85.41 156.59 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.45 ' CG2' HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.467 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.426 ' CG ' HD12 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.45 HD22 ' CG2' ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -140.17 135.81 32.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -84.09 134.48 34.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 10.7 m -87.64 -61.53 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -64.34 144.9 56.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.98 -117.57 4.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 51.4 p -51.76 120.88 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 71.1 m -78.61 123.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -101.79 176.94 26.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.02 166.05 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.403 HG12 ' N ' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' HG12 ' A' ' 434' ' ' ILE . 22.1 p30 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.478 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.468 ' N ' HG23 ' A' ' 440' ' ' ILE . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -108.76 147.01 32.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -94.15 118.74 31.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 68.6 p -128.45 95.91 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.811 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.1 m -122.57 161.36 23.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.94 113.43 3.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 t -128.22 144.05 51.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.83 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 99.3 p -79.22 137.17 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.34 -147.65 16.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.05 151.9 21.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 429' ' ' CYS . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . 0.445 ' N ' HG11 ' A' ' 428' ' ' VAL . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.462 HG12 ' N ' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.462 ' N ' HG12 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.462 ' N ' HG22 ' A' ' 440' ' ' ILE . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.477 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.459 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.459 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -142.96 154.12 43.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -79.48 142.81 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 38.1 m -79.51 173.44 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.2 t -39.65 -61.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.856 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -166.63 54.24 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 53.9 m -108.85 75.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.919 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 9.1 t -111.17 134.07 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -54.51 -71.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -102.84 152.3 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.421 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.39 162.98 40.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 470' ' ' LYS . 1.8 tmmm? -84.91 122.11 28.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 58.5 m -84.49 116.51 23.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 38.2 p -85.76 95.2 9.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 417' ' ' SER . . . 112.1 66.63 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 416' ' ' GLY . 22.6 t -37.21 135.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 30.3 m -75.01 99.24 3.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.28 -77.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -137.8 142.13 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.527 HD12 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.459 HG22 ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 434' ' ' ILE . 19.2 p30 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.449 HG11 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.449 ' CD1' HG11 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' MET . . . . . 0.419 ' C ' HD13 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.45 ' N ' HD13 ' A' ' 461' ' ' LEU . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.527 ' CE1' HD12 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -121.13 148.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -92.26 131.59 37.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 67.4 p -110.87 129.73 55.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.359 . . . . 0.0 110.887 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 82.4 p -107.92 -43.63 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 169.27 95.29 0.1 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 7.4 t -42.55 137.43 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 44.1 t -99.91 -51.24 3.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -100.53 -160.17 27.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -69.04 149.59 48.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.465 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' THR . . . . . 0.408 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.465 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' MET . . . . . 0.486 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -145.84 160.86 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -79.05 141.33 37.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.3 t -68.52 -56.61 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.8 t -98.66 155.81 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 117.46 -136.33 12.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 m -110.98 100.29 9.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 87.5 p -104.52 166.94 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -112.97 -166.02 16.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -92.3 152.07 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.526 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 429' ' ' CYS . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . 0.41 ' N ' HG11 ' A' ' 428' ' ' VAL . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.519 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.4 ' O ' ' CG ' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.41 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.469 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.519 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.417 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 -123.62 166.73 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 3.4 tppp? -105.48 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.526 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 26.3 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.4 t -85.64 149.14 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.382 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -131.23 114.23 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -61.75 -111.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.3 m -102.73 104.05 14.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 5.2 t -80.62 -50.13 10.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 124.89 -127.14 6.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -89.64 159.4 17.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.547 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 431' ' ' GLY . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 434' ' ' ILE . 19.2 p30 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 422' ' ' PRO . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.423 HG11 ' CD1' ' A' ' 448' ' ' ILE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.423 ' CD1' HG11 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.421 ' CD ' HD12 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.421 HD12 ' CD ' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -133.53 153.56 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 0.0 OUTLIER -85.87 117.02 24.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.547 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 17.9 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 81.0 p -115.69 163.35 15.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 17.7 m -60.32 112.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -167.68 -35.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.6 t -101.19 63.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 69.9 m -134.35 98.84 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.05 -80.47 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -101.71 161.5 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.424 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . 0.409 ' N ' HG13 ' A' ' 428' ' ' VAL . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.458 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 461' ' ' LEU . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 469' ' ' ARG . 0.0 OUTLIER -144.05 152.02 40.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -91.89 118.57 30.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 75.8 m -122.72 109.49 14.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.0 t -118.91 167.13 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -138.58 129.43 4.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 19.0 m -111.09 143.21 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 0.0 110.85 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 38.1 m -64.79 106.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.51 -140.85 11.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -88.8 159.27 17.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 471' ' ' TYR . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.4 ' CD1' HG12 ' A' ' 443' ' ' VAL . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -119.63 142.59 48.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -83.48 38.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 471' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 47.0 m -108.06 110.87 22.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 28.0 t -65.29 -51.57 59.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.2 -130.69 10.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 54.9 p -132.65 141.34 48.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 36.0 p -68.91 126.79 30.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.61 138.03 2.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -47.71 161.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.554 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 446' ' ' ASN . 0.0 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.542 ' CB ' ' CZ ' ' A' ' 463' ' ' PHE . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -129.29 125.99 38.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -82.74 126.38 32.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.2 m -94.1 136.67 34.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.5 m -88.44 84.41 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -135.1 114.23 1.22 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.8 t -79.89 110.46 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.841 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 40.2 t -95.3 90.32 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 139.39 -100.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.495 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -119.37 151.08 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.452 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.461 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.47 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.416 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.454 ' CG1' HD13 ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.454 HD13 ' CG1' ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.59 165.55 27.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 471' ' ' TYR . 65.1 tttt -81.11 130.73 35.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 470' ' ' LYS . 1.9 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.0 m -88.91 -52.3 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 24.4 m -45.09 -48.62 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -151.37 147.06 16.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.5 m -118.48 143.47 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.891 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 15.4 m -75.11 154.81 37.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -66.42 -109.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.63 158.4 16.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.475 ' CG2' ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.475 ' OD1' ' CG2' ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.479 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.446 ' N ' HG23 ' A' ' 440' ' ' ILE . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.479 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.468 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.468 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -110.25 144.22 39.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -84.32 128.26 34.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 21.7 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.3 m -119.29 175.37 5.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.6 m -100.38 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 39.18 55.18 2.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 32.7 t -77.26 83.17 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 22.8 t -137.07 129.99 30.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 159.56 -120.28 0.95 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -84.96 152.4 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.469 ' N ' HG23 ' A' ' 440' ' ' ILE . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.45 ' CG ' HD12 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.45 HD12 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -142.42 154.1 44.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -86.06 120.5 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.2 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.1 m -70.59 145.15 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.9 t -105.79 124.87 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 136.19 147.38 5.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.451 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 60.5 p -46.12 126.78 7.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 65.1 p -103.51 158.19 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -83.75 -63.53 1.68 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.32 163.87 31.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.41 ' C ' HG13 ' A' ' 426' ' ' VAL . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.41 HG13 ' C ' ' A' ' 425' ' ' ASN . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 471' ' ' TYR . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.503 HD11 ' CZ ' ' A' ' 463' ' ' PHE . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 471' ' ' TYR . 10.9 mm-40 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.468 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.503 ' CZ ' HD11 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -145.19 171.88 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 471' ' ' TYR . 21.3 tttm -80.09 129.08 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 437' ' ' GLN . 8.1 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 t -122.91 137.96 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.6 m -116.88 113.02 21.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -50.7 104.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 8.2 m -84.51 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.833 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 23.1 t -86.68 121.66 29.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.85 -113.74 4.73 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.65 155.67 19.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.445 ' CD1' HG11 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.461 HD23 ' CZ ' ' A' ' 463' ' ' PHE . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.461 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 470' ' ' LYS . 10.6 ttm-85 -137.88 147.63 44.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 469' ' ' ARG . 19.7 ttpp -88.44 121.25 30.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 471' ' ' TYR . 1.9 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 30.9 m -114.35 -54.8 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 89.9 p -63.57 136.65 57.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.7 56.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 41.1 t -38.62 103.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 4.3 m -90.62 85.79 6.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.5 -134.48 28.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -75.79 155.45 35.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.512 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.411 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.435 ' N ' HG22 ' A' ' 440' ' ' ILE . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 446' ' ' ASN . 0.1 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.462 ' CD1' HG11 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 456' ' ' ASP . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' MET . . . . . 0.436 ' C ' ' CD1' ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.512 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -152.01 145.03 24.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -79.1 148.53 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 4.4 m -55.2 148.12 15.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.2 t -73.83 110.44 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -148.87 72.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 28.3 t -139.88 116.92 11.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 2.8 m -113.69 117.71 32.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -131.62 39.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -129.41 142.08 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.466 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 440' ' ' ILE . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' CYS . . . . . 0.403 ' N ' HG11 ' A' ' 428' ' ' VAL . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 422' ' ' PRO . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.453 ' N ' HG22 ' A' ' 440' ' ' ILE . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -139.51 138.85 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -83.41 129.91 35.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 471' ' ' TYR . 4.2 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 443' ' ' VAL . 69.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.422 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.3 m120 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 420' ' ' PHE . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.625 ' O ' HD13 ' A' ' 448' ' ' ILE . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 447' ' ' LYS . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.546 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.575 ' C ' HD12 ' A' ' 461' ' ' LEU . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.575 HD12 ' C ' ' A' ' 460' ' ' MET . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 448' ' ' ILE . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.677 HG23 HG22 ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 448' ' ' ILE . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 443' ' ' VAL . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.677 HG22 HG23 ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 461' ' ' LEU . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.478 HG21 HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 467' ' ' GLU . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 433' ' ' LEU . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.716 HG23 HG22 ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 462' ' ' GLU . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.716 HG22 HG23 ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 449' ' ' THR . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 428' ' ' VAL . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 440' ' ' ILE . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.416 ' CG2' HD22 ' A' ' 468' ' ' LEU . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.584 HD13 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.478 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 434' ' ' ILE . 0.3 OUTLIER 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 424' ' ' ASP . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.434 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.401 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.678 HG13 ' CD1' ' A' ' 448' ' ' ILE . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.678 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.625 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 460' ' ' MET . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.584 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.416 HD22 ' CG2' ' A' ' 426' ' ' VAL . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.463 ' O ' HG21 ' A' ' 443' ' ' VAL . 62.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.621 ' HB2' HD12 ' A' ' 440' ' ' ILE . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.417 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 436' ' ' LEU . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.939 HG23 ' OD1' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.939 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 433' ' ' LEU . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 448' ' ' ILE . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.714 HG22 HG23 ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.471 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.425 HD13 ' HG3' ' A' ' 452' ' ' PRO . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.704 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 460' ' ' MET . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.482 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.552 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.1 m-85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.428 ' HB2' HD12 ' A' ' 440' ' ' ILE . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' HE1' ' A' ' 463' ' ' PHE . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.646 ' HA ' HG22 ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.454 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.812 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.812 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 456' ' ' ASP . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 455' ' ' GLU . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.512 ' C ' HD12 ' A' ' 461' ' ' LEU . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.542 ' HE1' HD13 ' A' ' 433' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.821 ' O ' HG21 ' A' ' 443' ' ' VAL . 14.1 m-85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.444 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.454 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 0.3 OUTLIER 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.905 HG13 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.905 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.663 HG22 HG23 ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.434 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.434 HD12 ' C ' ' A' ' 460' ' ' MET . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.41 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.41 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 443' ' ' VAL . 98.8 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.429 ' CG2' HD22 ' A' ' 468' ' ' LEU . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.562 HD13 ' HE1' ' A' ' 463' ' ' PHE . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.863 HG23 ' OD1' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.863 ' OD1' HG23 ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 452' ' ' PRO . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.621 HG13 ' CD1' ' A' ' 448' ' ' ILE . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.621 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.643 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.643 HD13 ' CG ' ' A' ' 452' ' ' PRO . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.92 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.562 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' A' ' 463' ' ' PHE . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.427 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.573 ' CG1' HD11 ' A' ' 440' ' ' ILE . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.426 ' HG3' ' C ' ' A' ' 436' ' ' LEU . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 434' ' ' ILE . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.675 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.834 HG23 ' OD1' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.834 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 452' ' ' PRO . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 451' ' ' MET . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 448' ' ' ILE . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 443' ' ' VAL . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.555 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.404 ' C ' HD12 ' A' ' 461' ' ' LEU . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ARG . . . . . 0.427 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.577 ' O ' HG21 ' A' ' 443' ' ' VAL . 16.0 m-85 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.47 ' HB3' HD22 ' A' ' 436' ' ' LEU . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.652 HG23 ' OD1' ' A' ' 435' ' ' ASN . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.652 ' OD1' HG23 ' A' ' 434' ' ' ILE . 0.6 OUTLIER 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 433' ' ' LEU . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 450' ' ' ILE . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 420' ' ' PHE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.463 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.442 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.463 ' HE1' HD13 ' A' ' 433' ' ' LEU . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 468' ' ' LEU . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.496 HD13 ' HE1' ' A' ' 463' ' ' PHE . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.483 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.417 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 451' ' ' MET . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 448' ' ' ILE . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.522 ' CD1' HG13 ' A' ' 443' ' ' VAL . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.727 HG22 HG23 ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.792 ' HB2' HD11 ' A' ' 441' ' ' LEU . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 457' ' ' LEU . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.585 ' C ' HD12 ' A' ' 461' ' ' LEU . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.496 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.413 ' HG2' ' CD ' ' A' ' 467' ' ' GLU . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.413 ' CD ' ' HG2' ' A' ' 464' ' ' PRO . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 426' ' ' VAL . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.623 HG13 HD11 ' A' ' 440' ' ' ILE . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.597 ' O ' HD13 ' A' ' 448' ' ' ILE . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 447' ' ' LYS . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.451 ' CG ' HD13 ' A' ' 461' ' ' LEU . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 461' ' ' LEU . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.852 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.852 HD12 ' C ' ' A' ' 460' ' ' MET . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.573 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.423 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.62 ' CG1' HD11 ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.657 HD13 ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 441' ' ' LEU . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 420' ' ' PHE . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 462' ' ' GLU . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.844 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.949 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 447' ' ' LYS . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.657 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.449 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.476 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.553 HD13 ' HE1' ' A' ' 463' ' ' PHE . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.449 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.915 HG13 ' CD1' ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.915 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.653 HG22 HG23 ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.414 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.831 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 461' ' ' LEU . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.68 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.831 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.553 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.455 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 440' ' ' ILE . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 440' ' ' ILE . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 440' ' ' ILE . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.992 HG23 ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.992 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.455 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.411 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.691 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.691 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.68 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.488 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.488 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 443' ' ' VAL . 15.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.662 ' HB2' HD12 ' A' ' 440' ' ' ILE . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 424' ' ' ASP . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.456 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.688 HG13 HD12 ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.407 ' O ' HD13 ' A' ' 448' ' ' ILE . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.688 HD12 HG13 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 462' ' ' GLU . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.58 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.58 HD13 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.553 ' C ' HD12 ' A' ' 461' ' ' LEU . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 449' ' ' THR . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.461 ' N ' ' OE1' ' A' ' 427' ' ' GLU . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 429' ' ' CYS . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 428' ' ' VAL . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.718 HD22 HD22 ' A' ' 436' ' ' LEU . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 452' ' ' PRO . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.803 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.611 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.797 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 443' ' ' VAL . 9.1 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.6 HD13 ' HE1' ' A' ' 463' ' ' PHE . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 451' ' ' MET . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.559 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.583 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 461' ' ' LEU . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.583 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.6 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.408 ' O ' HG13 ' A' ' 426' ' ' VAL . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 425' ' ' ASN . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 433' ' ' LEU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.778 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.437 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.766 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.457 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.983 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 448' ' ' ILE . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.983 ' CD1' HG13 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.766 HG22 HG23 ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.899 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.73 HD22 ' HG2' ' A' ' 452' ' ' PRO . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.422 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.908 ' C ' HD12 ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.908 HD12 ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.778 ' CE1' HD13 ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 463' ' ' PHE . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.729 ' O ' HG21 ' A' ' 443' ' ' VAL . 45.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 452' ' ' PRO . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ILE . . . . . 0.769 HG23 HG22 ' A' ' 450' ' ' ILE . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 451' ' ' MET . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 420' ' ' PHE . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ILE . . . . . 0.633 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 462' ' ' GLU . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.769 HG22 HG23 ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' MET . . . . . 0.63 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.84 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.853 ' C ' HD12 ' A' ' 461' ' ' LEU . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.853 HD12 ' C ' ' A' ' 460' ' ' MET . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.77 ' HG3' HG23 ' A' ' 449' ' ' THR . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 448' ' ' ILE . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 65.8 m -135.68 170.11 16.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.5 t -112.47 -63.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 161.95 119.49 0.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 50.5 m -54.9 162.05 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 3.2 t -72.92 122.88 22.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 148.38 -155.76 26.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 443' ' ' VAL . 69.0 m-85 -80.21 153.7 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 470' ' ' LYS . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.422 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.3 m120 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 420' ' ' PHE . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.625 ' O ' HD13 ' A' ' 448' ' ' ILE . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 447' ' ' LYS . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.546 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.575 ' C ' HD12 ' A' ' 461' ' ' LEU . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.575 HD12 ' C ' ' A' ' 460' ' ' MET . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 448' ' ' ILE . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -142.12 139.01 32.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.891 ' HA ' HG12 ' A' ' 426' ' ' VAL . 16.1 pttp -79.96 124.95 29.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.1 t -110.59 144.95 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.6 m -56.23 168.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.52 -166.41 16.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 75.7 m -83.45 92.7 7.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 50.7 m -88.73 116.27 26.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.24 -139.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.71 149.22 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.677 HG23 HG22 ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 448' ' ' ILE . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 443' ' ' VAL . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.677 HG22 HG23 ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 461' ' ' LEU . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -148.13 155.78 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -86.82 125.69 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 18.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 5.8 t -70.64 98.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.3 t -41.3 107.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 146.45 -70.75 0.35 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 11.0 m -43.95 126.84 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 42.4 p -109.08 131.59 54.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 135.65 -170.92 22.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -85.41 156.59 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.478 HG21 HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 467' ' ' GLU . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 433' ' ' LEU . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.716 HG23 HG22 ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 462' ' ' GLU . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.716 HG22 HG23 ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 449' ' ' THR . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 428' ' ' VAL . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -140.17 135.81 32.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -84.09 134.48 34.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 10.7 m -87.64 -61.53 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -64.34 144.9 56.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.98 -117.57 4.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 51.4 p -51.76 120.88 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 71.1 m -78.61 123.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -101.79 176.94 26.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.02 166.05 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 440' ' ' ILE . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.416 ' CG2' HD22 ' A' ' 468' ' ' LEU . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.584 HD13 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.478 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 434' ' ' ILE . 0.3 OUTLIER 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 424' ' ' ASP . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.434 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.401 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.678 HG13 ' CD1' ' A' ' 448' ' ' ILE . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.678 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.625 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 460' ' ' MET . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.584 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.416 HD22 ' CG2' ' A' ' 426' ' ' VAL . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -108.76 147.01 32.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -94.15 118.74 31.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 68.6 p -128.45 95.91 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.811 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.1 m -122.57 161.36 23.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.94 113.43 3.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 t -128.22 144.05 51.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.83 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 99.3 p -79.22 137.17 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.34 -147.65 16.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.463 ' O ' HG21 ' A' ' 443' ' ' VAL . 62.6 m-85 -103.05 151.9 21.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.621 ' HB2' HD12 ' A' ' 440' ' ' ILE . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.417 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 436' ' ' LEU . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.939 HG23 ' OD1' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.939 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 433' ' ' LEU . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 448' ' ' ILE . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.714 HG22 HG23 ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.471 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.425 HD13 ' HG3' ' A' ' 452' ' ' PRO . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.704 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 460' ' ' MET . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.482 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -142.96 154.12 43.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -79.48 142.81 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 38.1 m -79.51 173.44 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.2 t -39.65 -61.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.856 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -166.63 54.24 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 53.9 m -108.85 75.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.919 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 9.1 t -111.17 134.07 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -54.51 -71.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.552 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.1 m-85 -102.84 152.3 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.428 ' HB2' HD12 ' A' ' 440' ' ' ILE . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' HE1' ' A' ' 463' ' ' PHE . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.646 ' HA ' HG22 ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.454 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.812 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.812 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 456' ' ' ASP . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 455' ' ' GLU . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.512 ' C ' HD12 ' A' ' 461' ' ' LEU . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.542 ' HE1' HD13 ' A' ' 433' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.39 162.98 40.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' A' ' 470' ' ' LYS . 1.8 tmmm? -84.91 122.11 28.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 58.5 m -84.49 116.51 23.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 38.2 p -85.76 95.2 9.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 417' ' ' SER . . . 112.1 66.63 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 416' ' ' GLY . 22.6 t -37.21 135.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 30.3 m -75.01 99.24 3.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.28 -77.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.821 ' O ' HG21 ' A' ' 443' ' ' VAL . 14.1 m-85 -137.8 142.13 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.444 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.454 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 435' ' ' ASN . 0.3 OUTLIER 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.905 HG13 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.905 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.663 HG22 HG23 ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.434 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.434 HD12 ' C ' ' A' ' 460' ' ' MET . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.41 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.41 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -121.13 148.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -92.26 131.59 37.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 67.4 p -110.87 129.73 55.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.359 . . . . 0.0 110.887 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 82.4 p -107.92 -43.63 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 169.27 95.29 0.1 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 7.4 t -42.55 137.43 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 44.1 t -99.91 -51.24 3.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -100.53 -160.17 27.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 443' ' ' VAL . 98.8 m-85 -69.04 149.59 48.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.429 ' CG2' HD22 ' A' ' 468' ' ' LEU . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.562 HD13 ' HE1' ' A' ' 463' ' ' PHE . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.863 HG23 ' OD1' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.863 ' OD1' HG23 ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 452' ' ' PRO . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.621 HG13 ' CD1' ' A' ' 448' ' ' ILE . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.621 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.643 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.643 HD13 ' CG ' ' A' ' 452' ' ' PRO . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.92 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.562 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' A' ' 463' ' ' PHE . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -145.84 160.86 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -79.05 141.33 37.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.3 t -68.52 -56.61 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.8 t -98.66 155.81 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 117.46 -136.33 12.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 m -110.98 100.29 9.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 87.5 p -104.52 166.94 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -112.97 -166.02 16.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -92.3 152.07 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.427 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.573 ' CG1' HD11 ' A' ' 440' ' ' ILE . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 434' ' ' ILE . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.675 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.834 HG23 ' OD1' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.834 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 452' ' ' PRO . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 451' ' ' MET . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 448' ' ' ILE . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 443' ' ' VAL . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.555 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.404 ' C ' HD12 ' A' ' 461' ' ' LEU . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.427 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 -123.62 166.73 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 3.4 tppp? -105.48 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 26.3 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.4 t -85.64 149.14 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.382 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -131.23 114.23 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -61.75 -111.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.3 m -102.73 104.05 14.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 5.2 t -80.62 -50.13 10.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 124.89 -127.14 6.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.577 ' O ' HG21 ' A' ' 443' ' ' VAL . 16.0 m-85 -89.64 159.4 17.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.47 ' HB3' HD22 ' A' ' 436' ' ' LEU . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.652 HG23 ' OD1' ' A' ' 435' ' ' ASN . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.652 ' OD1' HG23 ' A' ' 434' ' ' ILE . 0.6 OUTLIER 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 433' ' ' LEU . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 450' ' ' ILE . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 420' ' ' PHE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.463 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.442 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.463 ' HE1' HD13 ' A' ' 433' ' ' LEU . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -133.53 153.56 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 0.0 OUTLIER -85.87 117.02 24.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 17.9 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 81.0 p -115.69 163.35 15.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 17.7 m -60.32 112.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -167.68 -35.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.6 t -101.19 63.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 69.9 m -134.35 98.84 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.05 -80.47 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -101.71 161.5 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 468' ' ' LEU . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.496 HD13 ' HE1' ' A' ' 463' ' ' PHE . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.483 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.417 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 451' ' ' MET . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 448' ' ' ILE . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.522 ' CD1' HG13 ' A' ' 443' ' ' VAL . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.727 HG22 HG23 ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.792 ' HB2' HD11 ' A' ' 441' ' ' LEU . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 457' ' ' LEU . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.585 ' C ' HD12 ' A' ' 461' ' ' LEU . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.496 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.413 ' HG2' ' CD ' ' A' ' 467' ' ' GLU . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.413 ' CD ' ' HG2' ' A' ' 464' ' ' PRO . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 426' ' ' VAL . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.05 152.02 40.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -91.89 118.57 30.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 75.8 m -122.72 109.49 14.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.0 t -118.91 167.13 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -138.58 129.43 4.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 19.0 m -111.09 143.21 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 0.0 110.85 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 38.1 m -64.79 106.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.51 -140.85 11.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -88.8 159.27 17.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.623 HG13 HD11 ' A' ' 440' ' ' ILE . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 471' ' ' TYR . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.597 ' O ' HD13 ' A' ' 448' ' ' ILE . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 447' ' ' LYS . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.451 ' CG ' HD13 ' A' ' 461' ' ' LEU . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 461' ' ' LEU . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.852 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.852 HD12 ' C ' ' A' ' 460' ' ' MET . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -119.63 142.59 48.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -83.48 38.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 471' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 47.0 m -108.06 110.87 22.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 28.0 t -65.29 -51.57 59.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.2 -130.69 10.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 54.9 p -132.65 141.34 48.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 36.0 p -68.91 126.79 30.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.61 138.03 2.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.573 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.0 m-85 -47.71 161.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.423 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.62 ' CG1' HD11 ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.657 HD13 ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 441' ' ' LEU . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 420' ' ' PHE . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 462' ' ' GLU . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.844 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.949 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 447' ' ' LYS . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.657 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -129.29 125.99 38.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -82.74 126.38 32.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.2 m -94.1 136.67 34.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.5 m -88.44 84.41 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -135.1 114.23 1.22 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.8 t -79.89 110.46 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.841 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 40.2 t -95.3 90.32 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 139.39 -100.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.495 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -119.37 151.08 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.449 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.476 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.553 HD13 ' HE1' ' A' ' 463' ' ' PHE . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.449 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.915 HG13 ' CD1' ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.915 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.653 HG22 HG23 ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.414 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.831 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 461' ' ' LEU . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.68 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.831 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.553 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.59 165.55 27.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 471' ' ' TYR . 65.1 tttt -81.11 130.73 35.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 470' ' ' LYS . 1.9 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.0 m -88.91 -52.3 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 24.4 m -45.09 -48.62 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -151.37 147.06 16.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.5 m -118.48 143.47 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.891 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 15.4 m -75.11 154.81 37.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -66.42 -109.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.63 158.4 16.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.455 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 440' ' ' ILE . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 440' ' ' ILE . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 440' ' ' ILE . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.992 HG23 ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.992 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.455 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.411 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.691 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.691 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.68 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.488 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.488 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -110.25 144.22 39.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -84.32 128.26 34.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 21.7 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.3 m -119.29 175.37 5.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.6 m -100.38 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 39.18 55.18 2.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 32.7 t -77.26 83.17 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 22.8 t -137.07 129.99 30.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 159.56 -120.28 0.95 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 443' ' ' VAL . 15.9 m-85 -84.96 152.4 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.662 ' HB2' HD12 ' A' ' 440' ' ' ILE . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 424' ' ' ASP . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.456 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.688 HG13 HD12 ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.407 ' O ' HD13 ' A' ' 448' ' ' ILE . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.688 HD12 HG13 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 462' ' ' GLU . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.58 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.58 HD13 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.553 ' C ' HD12 ' A' ' 461' ' ' LEU . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 449' ' ' THR . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -142.42 154.1 44.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -86.06 120.5 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.2 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.1 m -70.59 145.15 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.9 t -105.79 124.87 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 136.19 147.38 5.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.451 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 60.5 p -46.12 126.78 7.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 65.1 p -103.51 158.19 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -83.75 -63.53 1.68 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.32 163.87 31.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 471' ' ' TYR . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 429' ' ' CYS . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 428' ' ' VAL . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.718 HD22 HD22 ' A' ' 436' ' ' LEU . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 452' ' ' PRO . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 471' ' ' TYR . 10.9 mm-40 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.803 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.611 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.797 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -145.19 171.88 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 471' ' ' TYR . 21.3 tttm -80.09 129.08 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 437' ' ' GLN . 8.1 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 t -122.91 137.96 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.6 m -116.88 113.02 21.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -50.7 104.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 8.2 m -84.51 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.833 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 23.1 t -86.68 121.66 29.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.85 -113.74 4.73 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 443' ' ' VAL . 9.1 m-85 -105.65 155.67 19.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 470' ' ' LYS . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.6 HD13 ' HE1' ' A' ' 463' ' ' PHE . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 451' ' ' MET . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.559 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.583 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 461' ' ' LEU . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.583 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.6 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 470' ' ' LYS . 10.6 ttm-85 -137.88 147.63 44.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.468 ' HA ' HG12 ' A' ' 426' ' ' VAL . 19.7 ttpp -88.44 121.25 30.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 471' ' ' TYR . 1.9 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 30.9 m -114.35 -54.8 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 89.9 p -63.57 136.65 57.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.7 56.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 41.1 t -38.62 103.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 4.3 m -90.62 85.79 6.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.5 -134.48 28.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -75.79 155.45 35.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.408 ' O ' HG13 ' A' ' 426' ' ' VAL . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 425' ' ' ASN . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 433' ' ' LEU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.778 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.437 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.766 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.457 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.983 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 448' ' ' ILE . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.983 ' CD1' HG13 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.766 HG22 HG23 ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.899 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.73 HD22 ' HG2' ' A' ' 452' ' ' PRO . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.422 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.908 ' C ' HD12 ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.908 HD12 ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.778 ' CE1' HD13 ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 463' ' ' PHE . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -152.01 145.03 24.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -79.1 148.53 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 4.4 m -55.2 148.12 15.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.2 t -73.83 110.44 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -148.87 72.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 28.3 t -139.88 116.92 11.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 2.8 m -113.69 117.71 32.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -131.62 39.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.729 ' O ' HG21 ' A' ' 443' ' ' VAL . 45.4 m-85 -129.41 142.08 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 470' ' ' LYS . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 452' ' ' PRO . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ILE . . . . . 0.769 HG23 HG22 ' A' ' 450' ' ' ILE . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 451' ' ' MET . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 420' ' ' PHE . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.633 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 462' ' ' GLU . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.769 HG22 HG23 ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.63 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.84 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.853 ' C ' HD12 ' A' ' 461' ' ' LEU . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.853 HD12 ' C ' ' A' ' 460' ' ' MET . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.77 ' HG3' HG23 ' A' ' 449' ' ' THR . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 448' ' ' ILE . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -139.51 138.85 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.472 ' HA ' HG12 ' A' ' 426' ' ' VAL . 27.4 ttpt -83.41 129.91 35.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 471' ' ' TYR . 4.2 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 443' ' ' VAL . 69.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.427 HG12 ' ND2' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 434' ' ' ILE . 67.8 m-80 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 420' ' ' PHE . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.625 ' O ' HD13 ' A' ' 448' ' ' ILE . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 447' ' ' LYS . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.546 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.575 ' C ' HD12 ' A' ' 461' ' ' LEU . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.575 HD12 ' C ' ' A' ' 460' ' ' MET . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 448' ' ' ILE . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.419 ' ND2' HG12 ' A' ' 434' ' ' ILE . 6.8 m120 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.677 HG23 HG22 ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 448' ' ' ILE . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 443' ' ' VAL . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.677 HG22 HG23 ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 461' ' ' LEU . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.478 HG21 HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 467' ' ' GLU . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 433' ' ' LEU . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.716 HG23 HG22 ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 462' ' ' GLU . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.716 HG22 HG23 ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 449' ' ' THR . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 428' ' ' VAL . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 440' ' ' ILE . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.416 ' CG2' HD22 ' A' ' 468' ' ' LEU . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.584 HD13 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.583 HG23 ' ND2' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.583 ' ND2' HG23 ' A' ' 434' ' ' ILE . 22.1 p30 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 424' ' ' ASP . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.434 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.401 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.678 HG13 ' CD1' ' A' ' 448' ' ' ILE . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.678 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.625 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 460' ' ' MET . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.584 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.416 HD22 ' CG2' ' A' ' 426' ' ' VAL . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.463 ' O ' HG21 ' A' ' 443' ' ' VAL . 62.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.621 ' HB2' HD12 ' A' ' 440' ' ' ILE . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.417 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 436' ' ' LEU . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.939 HG23 ' OD1' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.939 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 433' ' ' LEU . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 448' ' ' ILE . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.714 HG22 HG23 ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.471 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.425 HD13 ' HG3' ' A' ' 452' ' ' PRO . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.704 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 460' ' ' MET . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.482 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.552 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.1 m-85 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.428 ' HB2' HD12 ' A' ' 440' ' ' ILE . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' HE1' ' A' ' 463' ' ' PHE . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.646 ' HA ' HG22 ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.454 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.812 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.812 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 456' ' ' ASP . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 455' ' ' GLU . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.512 ' C ' HD12 ' A' ' 461' ' ' LEU . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.542 ' HE1' HD13 ' A' ' 433' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.821 ' O ' HG21 ' A' ' 443' ' ' VAL . 14.1 m-85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.444 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.49 HG23 ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.49 ' ND2' HG23 ' A' ' 434' ' ' ILE . 19.2 p30 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.905 HG13 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.905 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.663 HG22 HG23 ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.434 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.434 HD12 ' C ' ' A' ' 460' ' ' MET . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.41 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.41 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 443' ' ' VAL . 98.8 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.429 ' CG2' HD22 ' A' ' 468' ' ' LEU . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.562 HD13 ' HE1' ' A' ' 463' ' ' PHE . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.863 HG23 ' OD1' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.863 ' OD1' HG23 ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 452' ' ' PRO . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.621 HG13 ' CD1' ' A' ' 448' ' ' ILE . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.621 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.643 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.643 HD13 ' CG ' ' A' ' 452' ' ' PRO . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.92 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.562 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' A' ' 463' ' ' PHE . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.427 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.573 ' CG1' HD11 ' A' ' 440' ' ' ILE . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.426 ' HG3' ' C ' ' A' ' 436' ' ' LEU . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 434' ' ' ILE . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.675 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.834 HG23 ' OD1' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.834 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 452' ' ' PRO . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 451' ' ' MET . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 448' ' ' ILE . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 443' ' ' VAL . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.555 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.404 ' C ' HD12 ' A' ' 461' ' ' LEU . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . 0.427 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.577 ' O ' HG21 ' A' ' 443' ' ' VAL . 16.0 m-85 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.47 ' HB3' HD22 ' A' ' 436' ' ' LEU . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 435' ' ' ASN . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 434' ' ' ILE . 19.2 p30 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 433' ' ' LEU . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 450' ' ' ILE . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 420' ' ' PHE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.463 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.442 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.463 ' HE1' HD13 ' A' ' 433' ' ' LEU . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 468' ' ' LEU . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.496 HD13 ' HE1' ' A' ' 463' ' ' PHE . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.483 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.417 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 451' ' ' MET . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 448' ' ' ILE . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.522 ' CD1' HG13 ' A' ' 443' ' ' VAL . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.727 HG22 HG23 ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.792 ' HB2' HD11 ' A' ' 441' ' ' LEU . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 457' ' ' LEU . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.585 ' C ' HD12 ' A' ' 461' ' ' LEU . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.496 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.413 ' HG2' ' CD ' ' A' ' 467' ' ' GLU . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.413 ' CD ' ' HG2' ' A' ' 464' ' ' PRO . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 426' ' ' VAL . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.623 HG13 HD11 ' A' ' 440' ' ' ILE . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.597 ' O ' HD13 ' A' ' 448' ' ' ILE . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 447' ' ' LYS . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.451 ' CG ' HD13 ' A' ' 461' ' ' LEU . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 461' ' ' LEU . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.852 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.852 HD12 ' C ' ' A' ' 460' ' ' MET . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.573 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.423 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.62 ' CG1' HD11 ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.657 HD13 ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 441' ' ' LEU . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 420' ' ' PHE . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.688 ' H ' ' ND2' ' A' ' 446' ' ' ASN . 0.0 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 462' ' ' GLU . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.844 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.949 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 447' ' ' LYS . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.657 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.449 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.476 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.553 HD13 ' HE1' ' A' ' 463' ' ' PHE . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.449 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.915 HG13 ' CD1' ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.915 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.653 HG22 HG23 ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.414 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.831 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 461' ' ' LEU . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.68 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.831 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.553 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.455 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 440' ' ' ILE . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 440' ' ' ILE . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 440' ' ' ILE . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.992 HG23 ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.992 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.455 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.411 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.691 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.691 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.68 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.488 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.488 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 443' ' ' VAL . 15.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.662 ' HB2' HD12 ' A' ' 440' ' ' ILE . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 424' ' ' ASP . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.456 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.688 HG13 HD12 ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.407 ' O ' HD13 ' A' ' 448' ' ' ILE . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.688 HD12 HG13 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 462' ' ' GLU . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.58 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.58 HD13 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.553 ' C ' HD12 ' A' ' 461' ' ' LEU . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 449' ' ' THR . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 427' ' ' GLU . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 429' ' ' CYS . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 428' ' ' VAL . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.718 HD22 HD22 ' A' ' 436' ' ' LEU . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 452' ' ' PRO . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.803 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.611 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.797 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 443' ' ' VAL . 9.1 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.6 HD13 ' HE1' ' A' ' 463' ' ' PHE . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 451' ' ' MET . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.559 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.583 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 461' ' ' LEU . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.583 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.6 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.408 ' O ' HG13 ' A' ' 426' ' ' VAL . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 425' ' ' ASN . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 433' ' ' LEU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.778 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.437 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.766 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.457 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.983 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.468 ' H ' ' ND2' ' A' ' 446' ' ' ASN . 0.1 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 448' ' ' ILE . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.983 ' CD1' HG13 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.766 HG22 HG23 ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.899 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.73 HD22 ' HG2' ' A' ' 452' ' ' PRO . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.422 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.908 ' C ' HD12 ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.908 HD12 ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.778 ' CE1' HD13 ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 463' ' ' PHE . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.729 ' O ' HG21 ' A' ' 443' ' ' VAL . 45.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 452' ' ' PRO . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . 0.769 HG23 HG22 ' A' ' 450' ' ' ILE . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 451' ' ' MET . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 420' ' ' PHE . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ILE . . . . . 0.633 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 462' ' ' GLU . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.769 HG22 HG23 ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' MET . . . . . 0.63 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.84 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.853 ' C ' HD12 ' A' ' 461' ' ' LEU . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.853 HD12 ' C ' ' A' ' 460' ' ' MET . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.77 ' HG3' HG23 ' A' ' 449' ' ' THR . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 448' ' ' ILE . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 65.8 m -135.68 170.11 16.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 8.5 t -112.47 -63.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 161.95 119.49 0.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 50.5 m -54.9 162.05 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 3.2 t -72.92 122.88 22.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.859 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 148.38 -155.76 26.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.618 ' O ' HG21 ' A' ' 443' ' ' VAL . 69.0 m-85 -80.21 153.7 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.887 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -120.09 143.46 35.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.78 160.37 49.94 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.602 2.201 . . . . 0.0 112.365 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.05 -35.73 4.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -68.59 156.76 37.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.326 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.1 120.05 36.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 470' ' ' LYS . 30.0 m -133.02 174.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.117 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.429 ' CG ' ' N ' ' A' ' 428' ' ' VAL . 13.7 tt0 -145.17 160.07 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.429 ' N ' ' CG ' ' A' ' 427' ' ' GLU . 94.3 t -76.59 133.51 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.125 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.5 t -95.07 -44.8 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -134.51 161.47 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.54 -168.18 12.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -80.11 -32.71 39.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.467 HD13 ' CE1' ' A' ' 463' ' ' PHE . 6.2 mt -87.2 23.6 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.427 HG12 ' ND2' ' A' ' 435' ' ' ASN . 16.8 tt -54.65 159.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.122 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 434' ' ' ILE . 67.8 m-80 56.21 31.24 18.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 19.5 tp -114.36 112.69 23.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.52 162.93 12.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 170.97 179.58 42.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -101.29 148.0 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 450' ' ' ILE . 35.6 mt -86.85 136.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 32.5 mt -98.52 -51.1 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 55.4 m -149.9 173.56 13.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 420' ' ' PHE . 90.7 t -126.84 116.73 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.65 80.75 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.39 -111.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.479 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -73.08 -31.87 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.625 ' O ' HD13 ' A' ' 448' ' ' ILE . 18.4 mtmm -93.97 145.86 24.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.625 HD13 ' O ' ' A' ' 447' ' ' LYS . 11.4 mm -126.36 113.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 5.0 m -85.19 115.68 23.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.172 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 440' ' ' ILE . 16.7 pt -135.37 -175.01 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.6 ttm -136.58 117.79 11.29 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.546 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.4 Cg_endo -69.78 147.34 62.52 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.673 2.249 . . . . 0.0 112.357 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -90.83 84.99 5.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.09 128.51 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -58.82 -45.38 90.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -48.17 -43.35 31.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 24.3 mt -85.13 129.0 34.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.31 40.35 3.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -162.41 159.74 25.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.575 ' C ' HD12 ' A' ' 461' ' ' LEU . 3.6 ptp -84.37 158.34 21.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.575 HD12 ' C ' ' A' ' 460' ' ' MET . 5.0 mp -133.85 162.53 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.933 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -126.33 124.28 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.467 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.9 m-85 -127.3 152.13 75.7 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.625 0.726 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.45 54.31 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.643 2.229 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.25 -28.91 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.62 -35.07 70.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 448' ' ' ILE . 57.9 mt -92.64 143.41 26.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -142.12 139.01 32.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.891 ' HA ' HG12 ' A' ' 426' ' ' VAL . 16.1 pttp -79.96 124.95 29.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.1 t -110.59 144.95 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.939 0.399 . . . . 0.0 110.862 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.6 m -56.23 168.05 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 103.52 -166.41 16.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 75.7 m -83.45 92.7 7.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 50.7 m -88.73 116.27 26.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.847 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.24 -139.95 0.1 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.71 149.22 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -117.17 143.64 32.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.415 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.75 158.96 55.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 110.62 -24.78 16.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.489 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -80.87 160.2 24.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 110.854 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.8 120.17 34.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.03 169.57 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 32.6 tt0 -142.2 166.45 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 434' ' ' ILE . 99.0 t -82.57 124.46 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.0 t -82.74 -46.79 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.84 168.55 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 172.98 26.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.17 -13.88 62.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.873 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 mt -91.71 -3.03 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.469 ' HA ' ' CG1' ' A' ' 428' ' ' VAL . 17.8 tt -41.63 155.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.419 ' ND2' HG12 ' A' ' 434' ' ' ILE . 6.8 m120 65.93 26.01 11.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 31.9 tp -113.16 109.27 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -99.43 158.99 15.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 174.55 176.45 42.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -98.88 147.16 25.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.677 HG23 HG22 ' A' ' 450' ' ' ILE . 34.6 mt -87.29 131.88 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 93.1 mt -93.85 -52.64 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 87.2 p -144.85 164.54 30.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 448' ' ' ILE . 32.2 t -128.78 113.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -117.48 98.47 6.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 46.05 -114.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.515 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -83.28 -29.0 28.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.875 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -88.41 125.39 34.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.561 HG23 HG22 ' A' ' 443' ' ' VAL . 3.8 mm -116.19 111.9 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.091 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 19.2 m -82.4 109.56 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.677 HG22 HG23 ' A' ' 440' ' ' ILE . 13.1 pt -127.89 178.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.9 tpt -131.37 115.38 16.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 0.0 110.89 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.545 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.2 Cg_endo -69.75 153.53 68.88 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 0.0 112.373 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -93.97 80.11 4.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.85 118.96 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -43.71 -50.15 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 -63.29 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.9 mt -72.29 101.55 2.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -87.63 -35.66 17.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.77 160.61 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.47 159.46 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 461' ' ' LEU . 2.9 mp -128.62 167.55 17.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -125.28 128.04 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -130.17 147.17 64.63 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.648 0.737 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 466' ' ' GLN . 53.2 Cg_endo -69.77 150.05 67.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.27 . . . . 0.0 112.335 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.02 -23.67 5.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.054 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 464' ' ' PRO . 2.8 pt20 -74.54 -30.93 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.419 ' CD ' ' HD2' ' A' ' 464' ' ' PRO . 27.7 mt-10 -80.8 -39.37 26.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.9 mt -92.65 141.4 28.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -148.13 155.78 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -86.82 125.69 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 18.9 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 5.8 t -70.64 98.67 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.3 t -41.3 107.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 146.45 -70.75 0.35 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 11.0 m -43.95 126.84 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 42.4 p -109.08 131.59 54.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 135.65 -170.92 22.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -85.41 156.59 20.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -121.07 142.19 34.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.76 160.99 47.66 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.683 2.256 . . . . 0.0 112.335 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.4 -19.82 28.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.76 168.57 16.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.66 120.86 43.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.478 HG21 HD22 ' A' ' 468' ' ' LEU . 27.3 m -124.76 -177.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.7 133.51 8.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 467' ' ' GLU . 59.9 t -60.51 136.91 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 8.8 t -88.67 -44.03 10.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -140.73 164.09 31.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 107.64 153.64 18.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 5.6 mm-40 -35.65 -41.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.917 0.389 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 463' ' ' PHE . 11.0 mt -86.23 39.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.3 tt -69.26 163.81 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.175 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 434' ' ' ILE . 20.8 p30 45.47 33.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 433' ' ' LEU . 14.1 tp -104.94 102.99 12.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -90.91 160.38 15.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.04 177.8 41.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.56 151.47 21.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.729 0.3 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.716 HG23 HG22 ' A' ' 450' ' ' ILE . 19.8 mt -90.49 135.4 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.135 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 60.0 mt -96.55 -52.15 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 57.7 m -153.13 161.8 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 448' ' ' ILE . 71.4 t -115.11 125.19 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.03 84.85 2.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 50.72 -122.13 12.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -70.39 -28.55 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.932 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -93.97 141.01 29.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.8 mm -123.56 111.46 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 462' ' ' GLU . 13.7 m -80.89 115.2 20.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.716 HG22 HG23 ' A' ' 440' ' ' ILE . 9.3 pt -135.55 -175.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 5.3 ttm -140.91 116.33 7.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.548 0.69 . . . . 0.0 110.882 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.79 163.56 37.85 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -108.53 85.53 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -151.71 126.61 9.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -46.31 -48.84 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -44.93 -68.24 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.436 HD13 ' CG ' ' A' ' 452' ' ' PRO . 11.0 mt -60.94 142.13 56.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -122.44 -31.16 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -102.61 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.12 164.92 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 463' ' ' PHE . 2.9 mp -132.47 179.81 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 449' ' ' THR . 14.5 mt-10 -137.86 129.57 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -136.62 146.68 56.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.729 . . . . 0.0 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 164.85 32.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.83 -30.09 67.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.09 -39.4 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 428' ' ' VAL . 36.9 mt-10 -87.04 13.21 9.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 426' ' ' VAL . 14.9 mt -140.66 125.15 17.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -140.17 135.81 32.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -84.09 134.48 34.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 10.7 m -87.64 -61.53 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -64.34 144.9 56.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 80.98 -117.57 4.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 51.4 p -51.76 120.88 5.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 71.1 m -78.61 123.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.837 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -101.79 176.94 26.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.02 166.05 10.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -121.7 141.87 34.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.7 Cg_endo -69.71 162.5 41.82 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 90.64 4.84 69.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.739 ' HB2' HD12 ' A' ' 440' ' ' ILE . 73.2 m-20 -94.26 168.54 10.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -97.49 125.11 41.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.416 ' CG2' HD22 ' A' ' 468' ' ' LEU . 33.1 m -139.17 162.66 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 3.6 tm-20 -140.9 130.38 23.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.946 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.444 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 96.8 t -51.11 142.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.8 t -109.25 -24.68 10.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -149.26 145.62 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 112.19 159.6 14.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -51.49 -21.78 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.584 HD13 ' CE1' ' A' ' 463' ' ' PHE . 31.7 mt -85.53 20.2 2.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.583 HG23 ' ND2' ' A' ' 435' ' ' ASN . 20.6 tt -59.71 165.28 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.583 ' ND2' HG23 ' A' ' 434' ' ' ILE . 22.1 p30 45.44 35.9 2.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 34.0 tp -116.92 109.18 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.27 146.93 23.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -167.31 174.3 42.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -107.54 139.62 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.739 HD12 ' HB2' ' A' ' 424' ' ' ASP . 27.3 mt -74.99 150.0 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.157 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.434 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 5.4 mt -113.87 -45.23 3.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.401 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 3.5 m -153.26 164.71 37.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.678 HG13 ' CD1' ' A' ' 448' ' ' ILE . 74.9 t -124.65 118.47 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -118.57 91.66 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.98 -106.83 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.453 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -83.54 -33.9 25.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.947 0.403 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -87.08 137.16 32.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.678 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.2 mm -127.84 108.79 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 3.6 m -80.88 120.13 24.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.695 HG22 HG23 ' A' ' 440' ' ' ILE . 16.6 pt -137.33 178.75 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.1 tpt -134.59 117.3 13.1 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.54 0.686 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.546 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.77 145.94 58.63 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 0.0 112.376 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -92.9 80.04 4.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -151.39 124.33 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -49.18 -37.37 22.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.11 -60.88 3.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.7 93.63 5.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -79.63 -38.59 33.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.96 158.6 31.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.625 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.2 OUTLIER -85.26 164.09 18.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 460' ' ' MET . 5.2 mp -135.55 170.17 16.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -137.17 122.37 19.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.584 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.6 m-85 -128.36 151.85 77.17 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.637 0.732 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 145.47 57.67 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.692 2.261 . . . . 0.0 112.385 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.74 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.132 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -76.73 -44.43 33.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.99 -32.54 73.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.416 HD22 ' CG2' ' A' ' 426' ' ' VAL . 41.8 mt -94.48 130.93 40.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -108.76 147.01 32.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -94.15 118.74 31.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 68.6 p -128.45 95.91 4.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.811 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.1 m -122.57 161.36 23.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 98.94 113.43 3.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 t -128.22 144.05 51.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.83 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 99.3 p -79.22 137.17 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.34 -147.65 16.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.463 ' O ' HG21 ' A' ' 443' ' ' VAL . 62.6 m-85 -103.05 151.9 21.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.33 . . . . 0.0 110.88 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -111.07 141.54 24.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 161.45 45.88 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.249 . . . . 0.0 112.349 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 440' ' ' ILE . . . 97.29 -5.32 62.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.621 ' HB2' HD12 ' A' ' 440' ' ' ILE . 31.4 m-20 -86.65 156.26 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -88.85 121.26 31.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.417 ' CG2' HD22 ' A' ' 468' ' ' LEU . 31.0 m -137.26 171.35 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -147.82 153.65 39.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 91.6 t -71.2 137.27 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 49.3 t -85.52 -50.81 6.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -136.53 163.34 30.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 106.66 160.14 21.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -47.12 -31.71 3.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.351 . . . . 0.0 110.872 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 436' ' ' LEU . 34.6 mt -84.06 22.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.939 HG23 ' OD1' ' A' ' 435' ' ' ASN . 20.3 tt -60.98 164.43 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.121 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.939 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.2 p-10 44.23 38.77 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.617 HD22 HD22 ' A' ' 433' ' ' LEU . 28.6 tp -109.72 103.19 11.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -81.3 149.28 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.2 39.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -105.19 146.79 28.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.307 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -81.0 145.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.091 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.4 mt -111.45 -36.84 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 65.9 p -159.58 165.61 32.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 448' ' ' ILE . 96.6 t -126.7 120.09 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.123 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.33 88.28 2.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.68 -114.17 1.03 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -75.36 -27.76 59.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -94.23 141.98 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 443' ' ' VAL . 3.4 mm -129.99 111.73 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 32.2 m -82.01 118.51 23.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.714 HG22 HG23 ' A' ' 440' ' ' ILE . 16.9 pt -138.32 178.78 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.7 ttm -137.77 118.37 10.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.566 0.698 . . . . 0.0 110.865 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.471 ' CD ' HD13 ' A' ' 461' ' ' LEU . 53.6 Cg_endo -69.8 163.31 38.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -109.82 79.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -131.98 179.31 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.78 -36.44 11.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.65 -65.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.425 HD13 ' HG3' ' A' ' 452' ' ' PRO . 23.1 mt -52.48 114.25 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -112.84 27.18 9.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -151.96 167.98 26.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.704 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -85.24 163.31 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 460' ' ' MET . 5.5 mp -133.31 170.63 15.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -131.77 118.54 20.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.1 m-85 -126.48 150.78 71.53 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.653 0.74 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.482 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 54.1 Cg_endo -69.75 148.59 65.48 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.719 2.279 . . . . 0.0 112.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.42 -15.89 1.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -86.75 -29.79 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.482 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 48.4 mm-40 -83.82 -18.56 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.836 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.417 HD22 ' CG2' ' A' ' 426' ' ' VAL . 42.4 mt -104.37 130.47 52.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -142.96 154.12 43.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -79.48 142.81 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 -179.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 38.1 m -79.51 173.44 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.2 t -39.65 -61.3 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.856 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -166.63 54.24 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 53.9 m -108.85 75.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.919 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 9.1 t -111.17 134.07 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -54.51 -71.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.552 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.1 m-85 -102.84 152.3 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -110.57 140.97 23.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.83 161.78 44.61 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 0.0 112.322 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.32 -8.8 53.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.546 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.428 ' HB2' HD12 ' A' ' 440' ' ' ILE . 12.2 m-20 -93.38 168.14 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -100.8 131.36 46.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.89 166.34 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 40.8 tt0 -139.31 162.2 35.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 83.1 t -84.0 135.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.113 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.3 t -109.2 -21.99 12.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.61 162.68 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 94.07 152.99 29.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.92 -24.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' HE1' ' A' ' 463' ' ' PHE . 30.2 mt -85.96 38.65 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.4 tt -73.28 160.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 60.11 34.48 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.37 104.1 11.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -100.53 152.79 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.41 -178.35 47.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -98.77 150.1 22.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.646 ' HA ' HG22 ' A' ' 450' ' ' ILE . 34.5 mt -87.12 138.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.454 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 26.1 mt -104.48 -46.25 4.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 41.2 m -154.85 162.24 41.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.812 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.5 t -125.72 111.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 447' ' ' LYS . 3.7 m-20 -100.57 87.35 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.71 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.5 -32.59 19.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 444' ' ' ASP . 35.1 mttp -88.89 140.73 29.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.812 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.3 mm -122.53 108.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 87.0 m -83.23 113.31 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.646 HG22 ' HA ' ' A' ' 440' ' ' ILE . 13.4 pt -133.44 -179.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 115.57 15.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.888 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 135.99 31.85 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -77.8 84.63 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -156.88 149.62 23.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 456' ' ' ASP . 11.3 pt-20 -74.08 -52.37 12.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 455' ' ' GLU . 4.7 m-20 -46.16 -61.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.5 109.23 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -93.05 -55.71 3.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.926 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.79 161.52 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.867 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.512 ' C ' HD12 ' A' ' 461' ' ' LEU . 9.9 ptp -86.92 169.41 12.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -133.06 173.54 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.78 114.02 12.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.542 ' HE1' HD13 ' A' ' 433' ' ' LEU . 5.6 m-85 -120.49 148.7 48.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.656 0.741 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.05 43.57 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.657 2.238 . . . . 0.0 112.391 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.89 -4.93 10.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 8.8 pt20 -94.09 -36.73 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 18.6 mt-10 -72.9 -38.76 66.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.03 149.46 21.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.39 162.98 40.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 470' ' ' LYS . 1.8 tmmm? -84.91 122.11 28.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 58.5 m -84.49 116.51 23.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.898 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 38.2 p -85.76 95.2 9.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 417' ' ' SER . . . 112.1 66.63 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 416' ' ' GLY . 22.6 t -37.21 135.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 30.3 m -75.01 99.24 3.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.28 -77.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.473 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.821 ' O ' HG21 ' A' ' 443' ' ' VAL . 14.1 m-85 -137.8 142.13 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.86 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -109.19 143.42 27.64 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.606 0.717 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.444 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.3 Cg_endo -69.84 157.51 60.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.636 2.224 . . . . 0.0 112.315 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.08 -36.11 4.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.486 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.67 177.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -113.05 117.11 31.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 440' ' ' ILE . 28.4 m -120.58 176.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -154.01 128.96 9.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 59.0 t -54.88 136.13 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 41.8 t -96.75 -40.48 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.407 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 15.4 tp10 -131.92 170.92 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 433' ' ' LEU . . . 92.34 145.05 15.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.485 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 tt0 -35.13 -33.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.87 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 463' ' ' PHE . 12.0 mt -84.77 38.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.49 HG23 ' ND2' ' A' ' 435' ' ' ASN . 19.7 tt -72.92 165.45 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.49 ' ND2' HG23 ' A' ' 434' ' ' ILE . 19.2 p30 48.37 34.69 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 28.4 tp -111.3 103.28 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.16 162.48 14.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 172.27 178.77 42.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.478 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -100.34 149.96 23.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 450' ' ' ILE . 28.5 mt -91.24 139.05 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 42.6 mt -100.17 -50.54 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 46.5 m -151.82 171.38 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.821 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.905 HG13 ' CD1' ' A' ' 448' ' ' ILE . 91.6 t -125.79 117.64 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.156 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.62 90.36 3.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 43.56 -103.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.32 -36.1 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -89.11 138.78 31.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.905 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.4 mm -121.04 111.64 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 41.3 m -79.19 114.25 17.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.663 HG22 HG23 ' A' ' 440' ' ' ILE . 6.4 pt -133.44 -179.84 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 20.4 tpp -134.43 107.34 11.06 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.515 0.674 . . . . 0.0 110.901 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 131.71 21.85 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.375 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.47 83.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -143.63 134.36 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -63.96 -44.56 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.48 -56.14 23.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 60.0 mt -75.34 124.52 27.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -106.4 -46.15 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -80.83 143.71 32.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.434 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.1 ptt? -68.86 166.13 18.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.434 HD12 ' C ' ' A' ' 460' ' ' MET . 5.9 mp -130.21 175.49 8.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -134.35 113.66 12.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 433' ' ' LEU . 10.2 m-85 -118.82 147.9 43.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.695 0.759 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.41 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.7 Cg_endo -69.76 153.69 68.63 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.64 2.227 . . . . 0.0 112.36 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.63 -32.06 39.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.31 -39.19 74.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.41 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -67.94 -40.77 83.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 81.3 mt -90.78 123.63 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -121.13 148.03 44.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -92.26 131.59 37.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.986 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 67.4 p -110.87 129.73 55.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.359 . . . . 0.0 110.887 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 82.4 p -107.92 -43.63 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 169.27 95.29 0.1 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 7.4 t -42.55 137.43 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 44.1 t -99.91 -51.24 3.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -100.53 -160.17 27.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.514 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 443' ' ' VAL . 98.8 m-85 -69.04 149.59 48.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.797 0.332 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.04 146.19 33.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.465 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.75 161.69 44.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.78 39.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -83.32 169.42 15.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -102.1 144.09 31.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.429 ' CG2' HD22 ' A' ' 468' ' ' LEU . 7.0 m -152.78 176.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.66 159.22 44.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.5 t -82.39 143.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 29.1 p -109.99 -29.44 8.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -141.79 161.81 37.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.76 164.78 26.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.33 -38.78 74.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.562 HD13 ' HE1' ' A' ' 463' ' ' PHE . 23.1 mt -82.52 38.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.863 HG23 ' OD1' ' A' ' 435' ' ' ASN . 13.3 tt -66.25 169.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.863 ' OD1' HG23 ' A' ' 434' ' ' ILE . 2.5 p-10 46.42 42.68 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 452' ' ' PRO . 44.6 tp -116.78 103.16 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.46 159.11 15.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 175.03 -176.28 47.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -100.83 146.9 26.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 450' ' ' ILE . 26.4 mt -86.57 144.1 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 10.7 mt -106.31 -49.62 3.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.958 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 t -152.17 174.4 13.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.621 HG13 ' CD1' ' A' ' 448' ' ' ILE . 88.3 t -132.9 113.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.91 85.53 2.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 55.11 -103.7 0.23 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.429 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -89.95 -28.22 19.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.885 0.374 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -85.12 143.49 28.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.621 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.5 mm -129.79 97.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 462' ' ' GLU . 73.7 m -73.23 112.02 8.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.623 HG22 HG23 ' A' ' 440' ' ' ILE . 17.7 pt -135.15 178.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 460' ' ' MET . 2.9 mtp -129.0 117.07 19.09 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.528 0.68 . . . . 0.0 110.881 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.643 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.9 Cg_endo -69.71 163.56 37.76 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -110.66 95.18 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -144.43 173.04 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.53 -24.62 15.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.94 -44.74 10.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.643 HD13 ' CG ' ' A' ' 452' ' ' PRO . 15.2 mt -61.34 138.36 58.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -121.56 -57.12 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.87 167.08 22.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.92 ' C ' HD12 ' A' ' 461' ' ' LEU . 11.7 ptt? -85.47 177.16 7.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.92 HD12 ' C ' ' A' ' 460' ' ' MET . 2.1 mp -148.56 172.5 14.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 449' ' ' THR . 2.9 pp20? -143.59 116.52 8.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.562 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.0 OUTLIER -114.99 154.21 47.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.706 0.765 . . . . 0.0 110.847 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 153.79 68.45 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.679 2.252 . . . . 0.0 112.358 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.14 -23.08 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -75.55 -45.55 37.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.58 -32.58 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.541 HD11 ' HD2' ' A' ' 463' ' ' PHE . 28.5 mt -97.11 136.16 38.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -145.84 160.86 41.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -79.05 141.33 37.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.3 t -68.52 -56.61 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.858 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.8 t -98.66 155.81 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 117.46 -136.33 12.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 47.0 m -110.98 100.29 9.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 87.5 p -104.52 166.94 10.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -112.97 -166.02 16.56 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -92.3 152.07 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -121.25 141.85 33.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.625 0.726 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.427 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.9 Cg_endo -69.72 162.94 40.12 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 105.05 -24.43 28.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -83.36 156.07 23.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.26 138.13 32.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.573 ' CG1' HD11 ' A' ' 440' ' ' ILE . 27.0 m -147.05 158.82 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 8.1 tt0 -133.11 135.63 45.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.64 138.1 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.52 -57.0 4.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 434' ' ' ILE . 9.6 tp10 -141.15 165.42 27.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 111.73 165.48 17.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.02 -21.08 1.61 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.675 HD13 ' CE1' ' A' ' 463' ' ' PHE . 17.0 mt -99.17 23.89 8.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.834 HG23 ' OD1' ' A' ' 435' ' ' ASN . 15.3 tt -66.37 167.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.834 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.3 p-10 44.96 28.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 452' ' ' PRO . 16.0 tp -100.29 103.12 14.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -84.29 134.84 34.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.15 175.01 41.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -102.12 151.32 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 450' ' ' ILE . 46.5 mt -86.87 131.81 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.134 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 451' ' ' MET . 70.7 mt -92.01 -51.3 5.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.4 m -151.34 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 448' ' ' ILE . 33.2 t -117.97 123.68 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -123.63 98.44 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 38.91 -102.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -90.8 -34.01 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -85.69 125.94 33.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 443' ' ' VAL . 11.0 mm -116.85 109.64 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 7.5 m -84.15 115.9 22.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 440' ' ' ILE . 13.0 pt -131.93 178.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.555 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -135.3 116.35 12.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 110.876 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.616 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.4 Cg_endo -69.79 153.5 68.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.245 . . . . 0.0 112.347 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -92.9 84.45 4.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -159.94 129.92 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -58.83 -48.09 82.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -47.21 -47.11 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.54 81.39 6.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -84.09 44.05 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -166.24 141.19 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.404 ' C ' HD12 ' A' ' 461' ' ' LEU . 2.2 ptt? -74.86 155.27 37.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 461' ' ' LEU . 3.4 mp -128.7 172.44 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -137.2 122.96 19.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 433' ' ' LEU . 4.8 m-85 -127.2 145.22 53.42 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.657 0.742 . . . . 0.0 110.904 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 148.47 65.51 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.695 2.263 . . . . 0.0 112.354 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.99 -36.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.14 -42.89 96.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.863 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.67 17.18 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 18.9 mt -140.42 121.97 15.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.427 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 1.3 ptm85 -123.62 166.73 15.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 3.4 tppp? -105.48 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 26.3 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 1.4 t -85.64 149.14 25.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.382 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.0 t -131.23 114.23 14.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -61.75 -111.01 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.3 m -102.73 104.05 14.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 0.0 110.836 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 5.2 t -80.62 -50.13 10.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 124.89 -127.14 6.24 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.577 ' O ' HG21 ' A' ' 443' ' ' VAL . 16.0 m-85 -89.64 159.4 17.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -119.36 142.18 32.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.592 0.711 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.486 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.7 159.61 52.8 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.662 2.241 . . . . 0.0 112.404 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.7 -27.88 10.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.58 177.16 6.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -110.19 130.75 55.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.403 ' CG1' HD11 ' A' ' 440' ' ' ILE . 31.7 m -138.18 162.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 471' ' ' TYR . 28.2 tt0 -135.87 147.71 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.14 141.99 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.07 -46.04 8.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -142.95 157.19 44.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 112.63 152.81 11.54 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -40.55 -26.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.47 ' HB3' HD22 ' A' ' 436' ' ' LEU . 20.5 mt -91.48 31.92 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.802 HG23 ' ND2' ' A' ' 435' ' ' ASN . 16.3 tt -66.0 162.41 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.802 ' ND2' HG23 ' A' ' 434' ' ' ILE . 19.2 p30 46.68 33.41 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 433' ' ' LEU . 22.1 tp -97.36 103.07 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.12 138.98 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -166.93 175.07 42.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.482 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -105.35 142.48 35.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 450' ' ' ILE . 51.3 mt -77.26 140.75 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.486 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 12.4 mt -104.3 -51.22 3.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 67.4 m -150.26 168.15 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 420' ' ' PHE . 80.3 t -122.15 120.57 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -116.28 81.86 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.65 -105.76 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -42.86 36.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 139.05 32.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.534 ' CD1' HG13 ' A' ' 443' ' ' VAL . 11.7 mm -120.36 112.36 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 8.9 m -80.92 117.54 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.7 pt -138.46 170.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -128.11 112.67 20.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.569 0.7 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.463 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.0 Cg_endo -69.73 155.17 66.73 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.721 2.28 . . . . 0.0 112.33 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -92.09 91.23 7.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -156.93 146.82 20.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -69.31 -48.18 62.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.56 -59.48 4.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 48.5 mt -72.6 98.47 2.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.82 -57.39 3.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.25 166.88 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.442 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -80.56 168.97 18.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.6 mp -129.05 174.98 9.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -133.86 128.98 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.463 ' HE1' HD13 ' A' ' 433' ' ' LEU . 3.6 m-85 -135.14 151.1 74.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.866 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.4 Cg_endo -69.75 135.5 30.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.74 -25.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 464' ' ' PRO . 5.0 mt-30 -73.79 -50.96 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.72 -37.58 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.18 127.4 36.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -133.53 153.56 51.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 471' ' ' TYR . 0.0 OUTLIER -85.87 117.02 24.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 427' ' ' GLU . 17.9 m-85 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 81.0 p -115.69 163.35 15.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 17.7 m -60.32 112.04 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -167.68 -35.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.6 t -101.19 63.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 110.883 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 69.9 m -134.35 98.84 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.88 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -69.05 -80.47 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -101.71 161.5 13.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.05 143.18 36.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.546 0.689 . . . . 0.0 110.948 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.73 157.62 59.81 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.32 20.17 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -76.58 178.89 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -110.25 130.35 55.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 468' ' ' LEU . 17.2 m -142.27 168.61 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 36.8 tt0 -147.69 157.03 43.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 47.4 t -73.74 138.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 44.6 t -100.25 -42.88 6.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -132.95 162.14 32.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.857 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 106.11 171.12 23.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.19 -26.2 68.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.902 0.382 . . . . 0.0 110.884 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.496 HD13 ' HE1' ' A' ' 463' ' ' PHE . 32.3 mt -91.68 31.02 1.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.483 HG12 ' N ' ' A' ' 435' ' ' ASN . 16.3 tt -69.67 160.51 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 434' ' ' ILE . 53.2 m-20 62.59 27.12 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.417 ' C ' ' HG3' ' A' ' 427' ' ' GLU . 26.8 tp -110.45 103.41 12.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -93.78 163.1 13.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 173.76 179.11 44.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -99.35 146.19 26.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.757 0.313 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 450' ' ' ILE . 36.6 mt -87.02 135.03 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 451' ' ' MET . 20.2 mt -97.77 -48.93 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 88.1 p -152.64 162.79 40.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.522 HG13 ' CD1' ' A' ' 448' ' ' ILE . 90.0 t -120.26 123.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.51 84.62 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.29 -118.55 5.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.73 -35.61 72.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -86.32 140.68 29.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.522 ' CD1' HG13 ' A' ' 443' ' ' VAL . 9.6 mm -123.24 113.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.168 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 10.7 m -84.75 113.54 21.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.727 HG22 HG23 ' A' ' 440' ' ' ILE . 19.8 pt -135.75 178.19 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.792 ' HB2' HD11 ' A' ' 441' ' ' LEU . 9.2 tpt -131.33 107.38 14.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.545 0.688 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 451' ' ' MET . 53.1 Cg_endo -69.83 153.51 68.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.314 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -97.32 94.73 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -156.22 133.38 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -49.07 -59.94 3.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -48.83 -65.59 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 457' ' ' LEU . 7.1 mp -60.41 126.87 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -119.62 -41.52 2.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.31 162.42 22.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.585 ' C ' HD12 ' A' ' 461' ' ' LEU . 4.6 ptt? -78.89 164.48 24.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -131.62 -179.79 5.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.24 130.02 26.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.496 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.0 m-85 -135.31 150.22 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 0.0 110.883 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.413 ' HG2' ' CD ' ' A' ' 467' ' ' GLU . 53.8 Cg_endo -69.76 143.55 51.21 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.339 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.67 -24.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.76 -50.25 14.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.413 ' CD ' ' HG2' ' A' ' 464' ' ' PRO . 0.1 OUTLIER -56.92 -41.36 78.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 426' ' ' VAL . 50.0 mt -90.77 141.94 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.05 152.02 40.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -91.89 118.57 30.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 75.8 m -122.72 109.49 14.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.0 t -118.91 167.13 12.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -138.58 129.43 4.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 19.0 m -111.09 143.21 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.92 0.39 . . . . 0.0 110.85 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 38.1 m -64.79 106.92 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.867 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 136.51 -140.85 11.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -88.8 159.27 17.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -123.07 142.65 38.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.643 0.735 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.8 Cg_endo -69.78 159.33 53.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.648 2.232 . . . . 0.0 112.32 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 118.17 -39.4 2.6 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 173.17 3.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.29 110.87 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.623 HG13 HD11 ' A' ' 440' ' ' ILE . 27.4 m -106.51 172.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.11 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 471' ' ' TYR . 68.7 tt0 -153.13 136.32 15.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.73 139.5 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.1 p -97.86 -40.31 8.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.42 165.94 26.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 103.14 143.53 13.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.457 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 431' ' ' GLY . 6.6 mm-40 -34.87 -34.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 431' ' ' GLY . 31.5 mt -87.47 39.66 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 431' ' ' GLY . 20.7 tt -79.08 163.1 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 62.41 30.88 17.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.7 103.23 11.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -102.16 144.72 30.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.0 -179.21 38.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -101.11 139.04 37.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 450' ' ' ILE . 37.2 mt -77.19 133.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 62.7 mt -98.73 -50.26 4.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 20.0 m -151.7 152.82 33.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 448' ' ' ILE . 70.0 t -110.44 120.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -116.48 81.02 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 44.07 -118.17 2.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.439 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.61 -35.04 79.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.597 ' O ' HD13 ' A' ' 448' ' ' ILE . 0.0 OUTLIER -90.05 145.33 25.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 447' ' ' LYS . 18.0 mm -130.6 105.91 12.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 17.6 m -80.4 117.56 21.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 440' ' ' ILE . 16.1 pt -140.0 175.47 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.98 107.44 20.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.863 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.451 ' CG ' HD13 ' A' ' 461' ' ' LEU . 53.5 Cg_endo -69.74 127.35 14.48 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.643 2.229 . . . . 0.0 112.325 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -72.0 106.84 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -163.99 150.44 11.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.803 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.95 -57.04 6.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -52.61 -65.37 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 461' ' ' LEU . 11.3 mt -57.34 120.01 7.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -108.4 -41.48 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 p30 -84.08 163.18 20.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.852 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -79.63 177.33 8.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.852 HD12 ' C ' ' A' ' 460' ' ' MET . 7.0 mp -140.43 172.28 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -134.57 113.97 12.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 461' ' ' LEU . 2.3 m-85 -121.05 153.82 57.84 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.674 0.749 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 172.0 13.42 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -82.62 20.14 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.92 -37.15 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.52 -32.23 65.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 95.1 mt -90.22 133.67 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -119.63 142.59 48.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -83.48 38.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' O ' ' CG ' ' A' ' 471' ' ' TYR . 15.9 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 47.0 m -108.06 110.87 22.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 28.0 t -65.29 -51.57 59.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 90.2 -130.69 10.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 54.9 p -132.65 141.34 48.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 36.0 p -68.91 126.79 30.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.61 138.03 2.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.465 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.573 ' O ' HG21 ' A' ' 443' ' ' VAL . 22.0 m-85 -47.71 161.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.329 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.25 141.57 24.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.73 . . . . 0.0 110.889 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.423 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 54.1 Cg_endo -69.75 174.85 8.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.327 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.16 -36.98 3.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -69.01 153.71 43.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 0.0 110.839 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.45 141.01 33.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.62 ' CG1' HD11 ' A' ' 440' ' ' ILE . 30.6 m -139.84 -176.31 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -163.94 142.09 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.41 143.15 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 51.7 t -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -141.97 145.93 35.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 123.48 158.82 10.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.524 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -43.7 -22.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.657 HD13 ' CE1' ' A' ' 463' ' ' PHE . 21.2 mt -97.12 28.99 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 431' ' ' GLY . 12.5 tt -66.29 161.42 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.152 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.21 32.21 7.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 40.0 tp -108.41 103.01 12.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.85 153.38 21.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.874 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -178.81 -169.75 39.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -123.77 145.19 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 450' ' ' ILE . 19.0 mt -75.24 146.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.15 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 441' ' ' LEU . 14.1 mt -114.66 -46.37 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.91 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 15.2 m -154.22 160.12 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.847 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 420' ' ' PHE . 54.8 t -117.14 122.52 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -121.37 83.13 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 48.93 -119.49 6.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.503 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.688 ' H ' ' ND2' ' A' ' 446' ' ' ASN . 0.0 OUTLIER -68.35 -30.14 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 0.0 110.879 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.413 ' HB3' ' CD ' ' A' ' 462' ' ' GLU . 13.0 mtmt -93.13 142.08 27.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 443' ' ' VAL . 5.2 mm -127.89 102.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 6.4 m -72.25 118.79 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 440' ' ' ILE . 5.9 pt -134.49 168.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.14 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.408 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -115.13 107.43 49.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.591 0.71 . . . . 0.0 110.892 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.7 Cg_endo -69.76 148.11 64.36 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.678 2.252 . . . . 0.0 112.338 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 90.69 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -149.55 134.93 18.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.06 -60.98 3.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -46.7 -68.22 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 79.2 mt -59.86 121.01 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -98.19 -60.41 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.7 162.59 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.844 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -81.97 -177.95 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.949 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.0 mp -148.93 149.77 31.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 447' ' ' LYS . 7.5 tt0 -116.1 125.21 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.657 ' CE1' HD13 ' A' ' 433' ' ' LEU . 7.1 m-85 -130.84 153.14 81.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.721 0.772 . . . . 0.0 110.852 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 152.19 69.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.246 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -49.42 -29.37 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -70.49 -35.11 73.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.51 23.45 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 22.1 mt -146.31 127.39 14.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -129.29 125.99 38.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -82.74 126.38 32.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.2 m -94.1 136.67 34.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.911 0.386 . . . . 0.0 110.837 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.5 m -88.44 84.41 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -135.1 114.23 1.22 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 1.8 t -79.89 110.46 15.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.841 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 40.2 t -95.3 90.32 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 139.39 -100.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.495 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -119.37 151.08 39.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -120.43 142.41 33.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.449 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.77 158.57 56.5 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.603 2.202 . . . . 0.0 112.379 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 111.22 -23.27 19.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -81.22 158.24 24.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.377 . . . . 0.0 110.826 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 425' ' ' ASN . 0.5 OUTLIER -96.97 127.38 42.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.97 173.81 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 18.0 tt0 -149.76 158.21 43.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.476 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 59.8 t -75.94 120.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.98 -45.53 18.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -138.21 167.06 22.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 113.4 173.31 18.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -65.04 -29.55 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.553 HD13 ' HE1' ' A' ' 463' ' ' PHE . 36.3 mt -93.93 25.39 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.457 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.2 tt -56.22 161.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.457 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 26.7 m-80 62.46 34.96 15.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 17.3 tp -115.66 109.17 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.4 160.16 14.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.22 179.12 42.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.43 147.86 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 450' ' ' ILE . 24.9 mt -85.07 135.69 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.449 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 22.8 mt -103.08 -46.3 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.937 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 26.7 p -150.95 163.17 39.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.915 HG13 ' CD1' ' A' ' 448' ' ' ILE . 97.6 t -127.59 106.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.9 87.93 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 45.13 -109.25 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.537 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -74.95 -38.79 61.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -86.92 143.05 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.915 ' CD1' HG13 ' A' ' 443' ' ' VAL . 4.1 mm -123.42 115.18 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 9.5 m -86.57 114.02 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.653 HG22 HG23 ' A' ' 440' ' ' ILE . 18.2 pt -133.15 174.75 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.414 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.0 110.78 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.703 . . . . 0.0 110.874 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.831 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.2 Cg_endo -69.88 137.27 34.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.638 2.225 . . . . 0.0 112.322 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -92.35 82.79 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -149.76 157.08 42.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 456' ' ' ASP . 6.4 mm-40 -73.79 -62.51 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 455' ' ' GLU . 60.7 m-20 -35.5 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.492 HD22 HD11 ' A' ' 461' ' ' LEU . 20.2 mt -74.74 141.13 44.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -120.94 -36.88 3.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -92.89 156.92 16.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.68 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -69.67 170.06 11.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.831 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -137.2 175.9 9.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -135.89 116.15 13.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.553 ' HE1' HD13 ' A' ' 433' ' ' LEU . 1.3 m-85 -122.56 152.73 62.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 137.15 34.74 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 464' ' ' PRO . 2.6 mt-30 -72.09 -51.68 20.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.878 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -34.99 70.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.9 125.31 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -142.59 165.55 27.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 471' ' ' TYR . 65.1 tttt -81.11 130.73 35.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 470' ' ' LYS . 1.9 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.0 m -88.91 -52.3 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 24.4 m -45.09 -48.62 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -151.37 147.06 16.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.521 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 37.5 m -118.48 143.47 46.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.891 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 15.4 m -75.11 154.81 37.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -66.42 -109.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.63 158.4 16.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -115.06 142.32 28.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.607 0.718 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.455 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.1 Cg_endo -69.71 168.07 22.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 440' ' ' ILE . . . 88.29 -5.1 85.17 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.444 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 440' ' ' ILE . 25.3 m-20 -84.28 154.95 22.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.751 0.31 . . . . 0.0 110.908 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -86.96 114.16 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 440' ' ' ILE . 17.5 m -128.36 163.82 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.085 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.437 ' CD ' ' O ' ' A' ' 428' ' ' VAL . 0.6 OUTLIER -146.93 138.05 24.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.437 ' O ' ' CD ' ' A' ' 427' ' ' GLU . 45.8 t -62.95 140.48 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 4.4 t -97.24 -36.41 10.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -143.91 165.83 26.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 102.2 157.85 26.12 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -43.96 -32.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 463' ' ' PHE . 22.2 mt -84.6 25.33 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.992 HG23 ' OD1' ' A' ' 435' ' ' ASN . 17.7 tt -59.71 164.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.992 ' OD1' HG23 ' A' ' 434' ' ' ILE . 1.8 p-10 45.2 33.8 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.44 110.52 21.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.84 153.51 19.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -177.06 177.33 48.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -105.14 140.28 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.734 0.302 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 450' ' ' ILE . 34.5 mt -75.55 150.74 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.455 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 12.1 mt -114.13 -45.6 3.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.411 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 57.9 m -153.98 165.24 36.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.691 HG13 ' CD1' ' A' ' 448' ' ' ILE . 95.2 t -125.18 113.93 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.92 81.99 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.84 -100.35 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -89.55 -33.27 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -85.8 130.42 34.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.691 ' CD1' HG13 ' A' ' 443' ' ' VAL . 30.8 mm -120.29 98.53 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 61.1 m -73.89 114.7 12.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.16 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 440' ' ' ILE . 18.6 pt -133.84 176.86 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 0.0 OUTLIER -121.61 107.39 36.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.58 0.705 . . . . 0.0 110.909 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.68 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 132.92 24.35 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 0.0 112.33 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -75.93 82.14 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -153.25 129.4 10.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -52.1 -48.08 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.64 -60.49 3.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.29 105.28 5.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -104.17 -30.55 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.79 164.27 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 38.3 mtm -81.26 144.89 31.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.68 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.4 mp -122.04 151.62 40.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -114.28 116.07 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 433' ' ' LEU . 12.1 m-85 -118.78 144.55 35.82 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.488 ' HG2' ' CG ' ' A' ' 467' ' ' GLU . 53.4 Cg_endo -69.84 138.56 37.84 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.365 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -41.13 -27.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 464' ' ' PRO . 16.0 tt0 -75.68 -42.37 51.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.488 ' CG ' ' HG2' ' A' ' 464' ' ' PRO . 4.2 mm-40 -64.22 -38.77 92.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.9 mt -90.18 120.77 31.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -110.25 144.22 39.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -84.32 128.26 34.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 21.7 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 17.3 m -119.29 175.37 5.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.6 m -100.38 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 39.18 55.18 2.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.521 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 32.7 t -77.26 83.17 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 22.8 t -137.07 129.99 30.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 159.56 -120.28 0.95 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 443' ' ' VAL . 15.9 m-85 -84.96 152.4 23.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.0 110.885 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -113.08 140.95 24.82 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.456 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 54.0 Cg_endo -69.78 167.42 24.51 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.239 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 95.16 -12.26 68.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.662 ' HB2' HD12 ' A' ' 440' ' ' ILE . 14.6 m-20 -80.79 154.52 27.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -92.12 117.68 30.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 21.5 m -133.67 -177.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -159.66 150.35 19.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.76 145.74 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 20.0 t -98.7 -37.11 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -147.23 170.0 18.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.78 152.96 24.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -41.63 -26.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.542 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.6 mt -94.82 43.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.403 ' CG1' ' N ' ' A' ' 435' ' ' ASN . 14.7 tt -77.73 166.95 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 434' ' ' ILE . 50.1 m-80 50.6 35.81 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 29.5 tp -112.52 104.88 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . 0.439 ' OE1' ' N ' ' A' ' 438' ' ' GLY . 1.1 pp0? -97.37 161.14 13.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.439 ' N ' ' OE1' ' A' ' 437' ' ' GLN . . . 170.2 -179.68 42.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.528 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -103.03 149.54 24.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 424' ' ' ASP . 31.2 mt -82.08 148.0 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.456 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 15.7 mt -109.1 -45.45 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 2.2 m -153.92 167.73 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.688 HG13 HD12 ' A' ' 448' ' ' ILE . 99.7 t -129.51 104.12 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -106.02 90.3 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 51.9 -112.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.453 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -84.08 -29.98 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.407 ' O ' HD13 ' A' ' 448' ' ' ILE . 28.0 mmtt -87.21 132.13 33.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.688 HD12 HG13 ' A' ' 443' ' ' VAL . 5.1 mm -123.35 106.41 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . 0.646 HG23 ' HG2' ' A' ' 462' ' ' GLU . 11.8 m -79.16 115.57 18.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.1 pt -130.22 179.2 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 459' ' ' ASP . 7.2 tpt -133.24 114.18 13.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.574 0.702 . . . . 0.0 110.849 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.58 ' CG ' HD13 ' A' ' 457' ' ' LEU . 53.4 Cg_endo -69.81 155.76 64.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.638 2.225 . . . . 0.0 112.346 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -99.67 89.21 4.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -162.56 138.29 7.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -67.61 -47.42 69.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.97 -47.08 33.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.58 HD13 ' CG ' ' A' ' 452' ' ' PRO . 39.7 mt -67.13 -68.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 58.31 37.75 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.954 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.452 ' C ' ' SD ' ' A' ' 451' ' ' MET . 5.2 t70 -163.49 156.03 18.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.553 ' C ' HD12 ' A' ' 461' ' ' LEU . 6.0 ptp -88.56 153.5 21.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 460' ' ' MET . 6.4 mp -132.52 178.9 6.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.646 ' HG2' HG23 ' A' ' 449' ' ' THR . 23.0 mt-10 -137.99 129.67 28.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 433' ' ' LEU . 2.3 m-85 -138.99 151.68 68.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 154.86 67.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.288 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -27.59 21.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 18.7 pt20 -73.63 -37.17 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 75.9 mm-40 -85.39 12.9 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.4 mt -136.89 133.14 35.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -142.42 154.1 44.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -86.06 120.5 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 8.2 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 2.1 m -70.59 145.15 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 16.9 t -105.79 124.87 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 136.19 147.38 5.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.451 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 60.5 p -46.12 126.78 7.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 65.1 p -103.51 158.19 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -83.75 -63.53 1.68 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -140.32 163.87 31.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 110.861 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -118.97 140.49 28.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.548 0.69 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.497 ' CB ' ' O ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.74 164.09 35.83 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.69 2.26 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 106.57 -25.77 21.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.56 162.5 26.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.76 127.77 43.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.59 168.07 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 471' ' ' TYR . 3.6 pm0 -140.97 159.27 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 429' ' ' CYS . 77.2 t -71.21 153.57 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . 0.407 ' N ' HG12 ' A' ' 428' ' ' VAL . 19.0 t -102.33 -42.6 5.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -141.97 155.11 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 434' ' ' ILE . . . 109.41 155.55 16.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -42.5 -29.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.362 . . . . 0.0 110.878 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.718 HD22 HD22 ' A' ' 436' ' ' LEU . 29.6 mt -85.71 24.93 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 431' ' ' GLY . 18.3 tt -66.7 163.82 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 47.33 31.98 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 452' ' ' PRO . 36.2 tp -99.42 105.63 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 471' ' ' TYR . 10.9 mm-40 -90.32 132.29 35.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -165.61 174.04 41.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -102.63 146.44 28.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 450' ' ' ILE . 39.3 mt -82.46 138.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 422' ' ' PRO . 14.1 mt -102.5 -56.49 2.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 23.2 p -144.51 160.86 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.54 107.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 447' ' ' LYS . 11.0 m-20 -101.56 85.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 42.15 -107.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -77.01 -31.17 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 444' ' ' ASP . 40.6 mtmt -91.1 136.07 33.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.4 106.64 19.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 26.6 m -79.91 118.36 21.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -139.82 165.53 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.41 ' HA ' ' HD2' ' A' ' 452' ' ' PRO . 8.6 tpt -112.02 107.45 55.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.864 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.803 ' HB3' HD21 ' A' ' 436' ' ' LEU . 53.6 Cg_endo -69.75 151.62 69.15 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.688 2.258 . . . . 0.0 112.381 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -95.51 96.95 9.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.58 152.68 16.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -77.34 -48.96 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.33 -46.32 76.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.93 106.33 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -106.55 46.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -174.31 156.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.611 ' C ' HD12 ' A' ' 461' ' ' LEU . 0.0 OUTLIER -76.08 165.9 24.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.797 HD13 ' HG3' ' A' ' 452' ' ' PRO . 6.8 mp -135.59 179.47 6.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -132.0 122.0 24.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.618 ' CE1' HD13 ' A' ' 433' ' ' LEU . 5.7 m-85 -129.42 147.54 65.55 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.625 0.726 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.6 Cg_endo -69.76 140.45 42.71 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.653 2.235 . . . . 0.0 112.363 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -40.75 -26.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 464' ' ' PRO . 14.1 tt0 -74.0 -49.12 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.36 -32.16 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 48.4 mt -96.35 129.99 43.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -145.19 171.88 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 471' ' ' TYR . 21.3 tttm -80.09 129.08 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 437' ' ' GLN . 8.1 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 23.2 t -122.91 137.96 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.6 m -116.88 113.02 21.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.879 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -50.7 104.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 8.2 m -84.51 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 110.833 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 23.1 t -86.68 121.66 29.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.85 -113.74 4.73 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.456 ' O ' HG21 ' A' ' 443' ' ' VAL . 9.1 m-85 -105.65 155.67 19.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.847 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.46 141.68 36.91 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.6 Cg_endo -69.78 166.64 26.94 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 0.0 112.353 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 103.69 -37.71 3.61 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.98 163.89 16.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.809 0.338 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -100.26 132.16 45.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 470' ' ' LYS . 17.4 m -145.74 170.29 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 21.8 tt0 -149.35 147.41 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 427' ' ' GLU . 80.7 t -60.58 131.24 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 25.4 p -109.24 -20.72 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -143.64 157.6 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 102.52 170.85 26.8 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.01 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.369 . . . . 0.0 110.869 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.6 HD13 ' HE1' ' A' ' 463' ' ' PHE . 39.3 mt -83.74 42.7 0.86 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 12.1 tt -72.17 167.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 56.85 33.88 23.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 18.4 tp -114.28 104.2 11.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -102.0 158.97 15.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.62 43.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -99.12 151.16 21.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.735 0.302 . . . . 0.0 110.931 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.651 ' HA ' HG22 ' A' ' 450' ' ' ILE . 41.1 mt -88.17 137.2 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 451' ' ' MET . 76.7 mt -98.98 -51.97 3.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.11 173.57 13.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.9 t -129.2 116.09 38.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -110.74 83.34 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.0 -109.31 0.54 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.28 -32.63 49.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -89.08 138.46 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 443' ' ' VAL . 25.7 mm -119.48 107.15 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.2 m -79.42 116.04 19.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.651 HG22 ' HA ' ' A' ' 440' ' ' ILE . 6.0 pt -135.32 179.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.559 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -130.36 107.39 16.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.605 0.716 . . . . 0.0 110.891 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.583 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.8 Cg_endo -69.7 149.72 67.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.399 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -88.53 91.24 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.16 121.0 3.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.78 -22.11 61.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.93 -41.63 67.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 461' ' ' LEU . 12.2 mt -92.87 89.14 6.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -83.75 45.41 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.9 161.98 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -86.34 158.12 19.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.583 HD13 ' HG3' ' A' ' 452' ' ' PRO . 7.4 mp -124.01 -178.89 4.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -141.71 115.9 9.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.6 ' HE1' HD13 ' A' ' 433' ' ' LEU . 2.7 m-85 -123.56 150.97 62.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.633 0.73 . . . . 0.0 110.904 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 160.07 51.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.95 -8.17 10.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.68 -35.82 12.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -34.0 67.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 77.8 mt -91.98 144.07 25.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 470' ' ' LYS . 10.6 ttm-85 -137.88 147.63 44.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.468 ' HA ' HG12 ' A' ' 426' ' ' VAL . 19.7 ttpp -88.44 121.25 30.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 471' ' ' TYR . 1.9 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.965 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 30.9 m -114.35 -54.8 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 89.9 p -63.57 136.65 57.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . 91.7 56.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 41.1 t -38.62 103.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.857 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 4.3 m -90.62 85.79 6.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.5 -134.48 28.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -75.79 155.45 35.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.899 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -114.27 139.66 24.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HB3' ' C ' ' A' ' 441' ' ' LEU . 53.9 Cg_endo -69.66 168.85 20.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.734 2.289 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 98.74 -22.08 42.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.482 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -85.63 140.45 30.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.408 ' O ' HG13 ' A' ' 426' ' ' VAL . 3.5 m120 -72.6 150.63 42.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 425' ' ' ASN . 30.2 m -156.85 -179.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 428' ' ' VAL . 45.0 tt0 -154.19 155.62 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 433' ' ' LEU . 33.2 t -82.8 130.63 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.41 -39.46 16.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -146.26 166.12 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 104.24 155.34 23.54 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -42.49 -28.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.778 HD13 ' CE1' ' A' ' 463' ' ' PHE . 35.7 mt -95.38 40.18 1.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.915 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.437 HG12 ' N ' ' A' ' 435' ' ' ASN . 19.7 tt -80.35 162.45 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.104 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . 0.437 ' N ' HG12 ' A' ' 434' ' ' ILE . 26.8 m-20 54.98 29.39 12.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.9 tp -110.3 104.3 13.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -87.63 144.97 26.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -171.12 -173.02 37.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -119.06 150.23 40.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.766 HG23 HG22 ' A' ' 450' ' ' ILE . 15.1 mt -82.47 147.04 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.457 ' C ' ' HB3' ' A' ' 422' ' ' PRO . 13.0 mt -115.88 -43.96 2.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 60.6 m -154.81 163.78 39.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.983 HG13 ' CD1' ' A' ' 448' ' ' ILE . 94.3 t -127.32 111.13 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -104.51 90.81 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 49.05 -97.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.468 ' H ' ' ND2' ' A' ' 446' ' ' ASN . 0.1 OUTLIER -91.03 -34.67 15.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.91 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 448' ' ' ILE . 58.9 mmtt -84.97 143.11 29.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.983 ' CD1' HG13 ' A' ' 443' ' ' VAL . 22.9 mm -124.51 96.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . . . . . . . . . 4.3 m -68.91 99.66 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.766 HG22 HG23 ' A' ' 440' ' ' ILE . 6.7 pt -115.57 171.76 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 11.0 tpt -114.42 107.35 51.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.899 ' HG3' HD13 ' A' ' 461' ' ' LEU . 54.1 Cg_endo -69.76 152.99 69.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -108.21 104.83 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -171.98 159.52 5.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.14 -53.64 7.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 457' ' ' LEU . 1.9 t70 -43.7 -69.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.73 HD22 ' HG2' ' A' ' 452' ' ' PRO . 2.0 pp -34.59 149.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 459' ' ' ASP . 1.5 pptp? -124.22 -17.12 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.927 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.422 ' CG ' ' HD2' ' A' ' 458' ' ' LYS . 6.3 m-20 -141.56 -177.77 5.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.908 ' C ' HD12 ' A' ' 461' ' ' LEU . 14.6 ptt? -85.86 178.28 7.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.908 HD12 ' C ' ' A' ' 460' ' ' MET . 5.8 mp -149.29 160.67 43.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.965 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -123.23 115.77 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.778 ' CE1' HD13 ' A' ' 433' ' ' LEU . 8.8 m-85 -114.47 147.87 38.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 466' ' ' GLN . 53.7 Cg_endo -69.77 142.71 48.61 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -42.13 -24.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.059 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 464' ' ' PRO . 23.4 tt0 -74.21 -44.17 54.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.62 27.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 463' ' ' PHE . 26.9 mt -148.8 132.94 17.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -152.01 145.03 24.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -79.1 148.53 32.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' SER . . . . . . . . . . . . . 4.4 m -55.2 148.12 15.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.831 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.2 t -73.83 110.44 8.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLY . . . . . . . . . . . . . . . -148.87 72.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' SER . . . . . . . . . . . . . 28.3 t -139.88 116.92 11.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' SER . . . . . . . . . . . . . 2.8 m -113.69 117.71 32.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -131.62 39.22 1.8 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.729 ' O ' HG21 ' A' ' 443' ' ' VAL . 45.4 m-85 -129.41 142.08 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -105.65 140.43 21.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HA ' ' CG2' ' A' ' 440' ' ' ILE . 53.8 Cg_endo -69.78 169.89 17.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 112.329 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 101.17 -47.87 1.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.435 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -52.95 173.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.69 129.09 54.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 470' ' ' LYS . 34.8 m -139.59 174.71 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -147.48 155.96 42.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 430' ' ' GLU . 57.3 t -81.97 135.63 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' CYS . . . . . . . . . . . . . 2.6 m -107.61 -25.68 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.479 ' O ' ' CG1' ' A' ' 428' ' ' VAL . 14.6 tt0 -126.51 166.05 17.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . 92.3 -166.75 29.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.477 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 22.2 pm0 -89.48 2.57 54.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 463' ' ' PHE . 18.5 mt -108.29 2.51 22.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.6 tt -40.0 145.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 63.72 39.68 8.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 452' ' ' PRO . 11.2 tp -115.3 103.02 10.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -75.39 143.95 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -175.12 -178.9 45.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -119.62 149.15 42.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . 0.769 HG23 HG22 ' A' ' 450' ' ' ILE . 13.9 mt -81.17 150.86 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 451' ' ' MET . 62.3 mt -117.45 -44.05 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . 0.413 ' N ' ' HB3' ' A' ' 422' ' ' PRO . 39.9 m -154.42 174.43 14.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 420' ' ' PHE . 69.2 t -132.17 120.17 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.168 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -122.43 95.85 4.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 47.13 -118.79 4.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -29.98 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 140.58 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.633 ' CD1' HG13 ' A' ' 443' ' ' VAL . 13.2 mm -126.69 107.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 462' ' ' GLU . 37.1 m -77.3 115.99 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.769 HG22 HG23 ' A' ' 440' ' ' ILE . 15.6 pt -133.51 175.1 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.63 ' HB2' HD11 ' A' ' 441' ' ' LEU . 0.0 OUTLIER -117.54 113.03 38.72 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.558 0.694 . . . . 0.0 110.898 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.84 ' HG3' HD13 ' A' ' 461' ' ' LEU . 53.8 Cg_endo -69.75 155.75 65.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 0.0 112.357 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -109.25 82.97 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -130.57 -178.89 4.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.73 -40.17 9.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.61 -64.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 19.6 mt -48.34 104.17 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -86.77 -54.51 4.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.35 163.15 28.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.853 ' C ' HD12 ' A' ' 461' ' ' LEU . 24.8 ptp -81.31 173.61 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.853 HD12 ' C ' ' A' ' 460' ' ' MET . 6.6 mp -135.36 -178.98 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.77 ' HG3' HG23 ' A' ' 449' ' ' THR . 5.0 mp0 -140.5 120.69 13.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.497 ' CE1' ' CD1' ' A' ' 433' ' ' LEU . 1.5 m-85 -127.97 151.37 75.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 164.6 33.9 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.72 -35.41 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.083 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 467' ' ' GLU . 12.1 pt20 -64.57 -43.34 94.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 466' ' ' GLN . 0.2 OUTLIER -83.65 21.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 448' ' ' ILE . 14.8 mt -144.89 127.66 16.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.958 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -139.51 138.85 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.472 ' HA ' HG12 ' A' ' 426' ' ' VAL . 27.4 ttpt -83.41 129.91 35.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 471' ' ' TYR . 4.2 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 stop_ save_